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Abstract Saponins are natural glycosides which
possess a wide range of pharmacological properties
including cytotoxic activity. In this review, the recent
studies (2005–2009) concerning the cytotoxic activity
of saponins have been summarized. The correlations
between the structure and the cytotoxicity of both
steroid and triterpenoid saponins have been described
as well as the most common mechanisms of action.
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AMPK AMP activated protein kinase
BiP Binding protein
BrDU Bromodeoxyuridine
CCAAT Cytidine-cytidine-adenosine-
adenosine-thymidine
CD Cluster of differentiation molecule
CDK Cyclin-dependent kinase
CEBP CCAAT-enhancer-binding protein
CHOP CEPB homology protein
Con A Concanavalin A
ER Endoplasmic reticulum
ERK Extracellular signal-regulated
kinase
GADD Growth arrest and DNA damage-
inducible gene
GRP Glucose regulated protein
hTERT Telomerase reverse transcriptase
JAK Janus kinase
MEK = MAPK Mitogen-activated protein kinase
MMP Matrix metalloproteinase
mTOR Mammalian target of rapamycin
NFjB Nuclear factor kappa-light-chain-
enhancer of activated B cells
NO Nitric oxide
PARP Poly ADP ribose polymerase
PCNA Proliferating cell nuclear antigen
PI3K Phosphoinositide-3-kinase
PP Protein phosphatase
PPAR-c Peroxisome proliferator-activated
receptor c
Raf Serine/threonine specific kinase
STAT Signal transducer and activator of
transcription
TIMP Tissue inhibitor of metallo-
proteinase
TSC Tuberous sclerosis complex
VEGF Vascular endothelial growth factor
XIAP X-linked inhibitor of apoptosis
protein
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Introduction
Saponins are secondary metabolites of glycosidic
nature widely distributed in higher plants but also
found in some animal sources, like e.g. marine
invertebrates. Despite their fairly large structural
diversity these compounds share some unique bio-
logical properties like the ability to lyse erythrocytes
or to foam (Bruneton1995; Rao and Gurfinkel 2000;
Francis et al. 2002). The latter contributed to naming
this group ‘‘saponins’’, which is derived from Latin
sapo meaning soap. Haemolysis of red blood cells
seems to result from saponin ability to form com-
plexes with cell membrane cholesterol leading in
consequence to pore formation and cell permeabili-
zation, and also to cause alterations in the negatively
charged carbohydrate portions on the cell surface
(Abe et al. 1981; Melzig et al. 2001; Gauthier et al.
2009a). It should be mentioned however that the
exact mechanism of haemolytic activity of saponins
is not clearly understood and is the subject of
discussions within the scientific community.
Surface activity responsible for foaming proper-
ties, as well as some other biological functions
including haemolytic activity, are attributed to char-
acteristic structural features of saponins and their
amphiphilic nature which results from the presence of
a hydrophilic sugar moiety and a hydrophobic genin
(called sapogenin). Saponins can possess from one to
three straight or branched sugar chains, most often
composed of D-glucose, L-rhamnose, D-galactose,
D-glucuronic acid, L-arabinose, D-xylose or D-fucose.
The sugar chain can contain from one to several
monosaccharide residues, and is usually attached at
C-3 (Vincken et al. 2007).
The aglycone may have steroid or triterpenoid
structure according to which saponins are usually
classified. Steroidal compounds are less common and
usually found among the Liliopsida (former Mono-
cotyledones) in members of such families as Lilia-
ceae, Dioscoreaceae, Agavaceae, while triterpenoid
saponins are more widely distributed and typical of
the Magnoliopsida families (former Dicotyledones),
e.g. Primulaceae, Sapotaceae, Caryophyllaceae and
others. In rare cases both types of saponins may
accumulate in a plant, like for example in Avena sp.
(monocotyledonous Poaceae) (Osbourn 2003) or
Lysimachia paridiformis (dicotyledonous Myrsina-
ceae) (Xu et al. 2007b).
Steroidal sapogenins (27C) can have a 6-ring
spirostane or a 5-ring furostane skeleton whereas in
the case of triterpenoid sapogenins (30C), which are
much more structurally diverse, the basic ring system
is most often made of five or, more seldom, of four
units. Pentacyclic triterpenoid saponins belong, in a
majority of cases, to oleanane-type, other skeleton
types include ursane, lupane, hopane, germanicane,
dammarane (Vincken et al. 2007). The presence in
the polycyclic sapogenin of different substituents,
such as for example hydroxyls, hydroxymethyls,
carboxyls and acyl groups, as well as differences in
the composition, linkage and number of sugar chains
account for significant structural diversity of saponins
and also their diverse bioactivity.
Saponins exert a wide range of pharmacological
activities including expectorant, antiinflammatory,
vasoprotective, hypocholesterolemic, immunomodu-
latory, hypoglycaemic, molluscicidal, antifungal,
antiparasitic and many others (Sparg et al. 2004;
Sahu et al. 2008). Plants rich in saponins, like Panax
ginseng or Glycyrrhiza glabra, have been used for
medicinal purposes since ancient times (Fiore et al.
2005) and to date continue to play a significant role
not only in medicine but also in food and cosmetic
industry, where they are utilized as emulsifiers or
sweeteners (Güçlü-Üstündağ and Mazza 2007).
Another important application of saponins is their
use as adjuvants in the production of vaccines (Sun
et al. 2009b). Steroidal sapogenins since many years
have served as economically important raw materials
for the pharmaceutical industry in the production of
steroidal hormones (Blunden et al. 1975; Güçlü-
Üstündağ and Mazza 2007).
Many reviews summarized different aspects
related to saponins, some of the more recent tackled
biosynthesis (Haralampidis et al. 2002; Kalinowska
et al. 2005), distribution (Henry 2005; Vincken et al.
2007), structures (Vincken et al. 2007; Sahu et al.
2008), biological and pharmacological activities of
saponins (Sparg et al. 2004; Yang et al. 2006; Wang
et al. 2007; Sun et al. 2009b), application and
processing (Güçlü-Üstündağ and Mazza 2007), meth-
ods employed in their analysis (Oleszek and Bialy
2006; Sahu et al. 2008) and chemical synthesis of
saponins (Yu et al. 2007; Yu and Sun 2009; Gauthier
et al. 2009b).
Cytotoxicity and the chemopreventive role of
saponins was also discussed in a number of review
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papers (Rao and Sung 1995; Konoshima 1996;
Shibata 2001; Kerwin 2004; Kim 2008; Bachran
et al. 2008; Fuchs et al. 2009). While most of these
focus on triterpenoids, and especially on ginseng and
soy saponins, chemopreventive and cancer control
activity of a steroidal sapogenin—diosgenin has been
recently summarized (Raju and Mehta 2009). Cyto-
toxicity of dioscins was also discussed in a review on
bioactive steroid saponins from the Dioscorea genus
(Sautour and Mitaine-Offer 2007). Bachran et al.
(Bachran et al. 2008) in their review of saponins
playing a role in tumor therapy focused on certain
groups of compounds, such as dioscins, saikosapo-
nins, julibrosides, avicins, soy and ginseng saponins,
and on combinations of saponins and conventional
anti-tumorigenic drugs.
This review focuses on the studies from the last
5 years referring to saponins for which cytotoxic
activity in vitro against human cancer cell lines was
reported. Some data from animal models are also
presented.
Due to enormous number of reports that appear
worldwide in which some reference to cytotoxicity is
made we had to set some limits. Thus, literature
searches were conducted in the following electronic
databases: MEDLINE/PubMed, SCOPUS/Elsevier,
Springer/ICM, INSPEC/ICM, SCI-Ex/ICM. The
search terms used were: saponins, cancer, cytotoxicity.
In this review special emphasis is given to studies
on structure-activity relationship and a summary of
mechanisms of action is also provided.
Cytotoxic saponins (2005–2009)
In the past 5 years a relatively large number of
publications devoted to various aspects of phyto-
chemical analysis of saponins contained also some
references to their biological activity including cyto-
toxicity. These data are summarized in Tables 1
and 2.
In the majority of cases, while structure elucida-
tion process was the main focus of the research,
cytotoxic activity tests were performed as additional
part of experimental studies. However, there was also
a considerable number of reports in which the
mechanisms of action or structure-activity relation-
ships were tackled in more detail and these are
reviewed in the following sections of this paper.
As far as cytotoxicity data are concerned the
following observations can be made. Most studies
were performed on a relatively narrow range of cell
lines, usually from one to five, sometimes up to ten.
The most notable exceptions in this respect are the
reports, in which isolated compounds were assayed by
National Cancer Institute (NCI) in anticancer drug
discovery screen. For example, Zhang (Zhang and Li
2007) tested triterpenoid saponins isolated from
Aesculus pavia against a panel of 59 cell lines from
nine different human cancers such as leukemia, non-
small cell lung, colon, CNS, melanoma, ovarian, renal,
prostate and breast. Similarly, cytotoxicity of seven
steroid saponins, isolated from Dioscorea collettii var.
hypoglauca, was compared on such a wide panel of
cancer cell lines (Sautour and Mitaine-Offer 2007).
One of the saponins, furostanol protoneodioscin
(NSC-698789) isolated from the rhizomes of this
plant, showed high activity against leukemia lines
(CCRF-CEM, K562 and MOLT-4), colon cancer lines
(HCT-15, KM12), CNS cancer line (SNB-75), mela-
noma line (M14), renal cancer line (CAKI-1), prostate
cancer (DU-145) and breast cancer line (MDA-MB-
435) with GI50 B 2.0 lmol l
-1. Leukemia, CNS can-
cer, and prostate cancer appeared the most sensitive
subpanels to protoneodioscin. A comparison with
other compounds in the NCI’s database indicated that
protoneodioscin had a novel mechanism of anticancer
action (Hu and Yao 2002). Also, the corresponding
methyl artifacts such as e.g. methyl protodioscin
(Fig. 1), have shown cytotoxic activity at concentra-
tions below 2 lmol l-1 in most studies performed so
far (Hu and Yao 2003a; Wang et al. 2006).
Generally, in most papers cited here, the choice of
cell lines seems to be random, most studies with a
wider range of lines use leukemia and solid tumors
cells.Very few studies compared cells from the same
tumor but differing in malignancy or other charac-
teristics. For example, Tapandjou et al. and Noté
et al. evaluated cytotoxicity of isolated triterpene
saponins against two colon cancer cell lines, HCT-
116 and HT-29 (Tapondjou et al. 2006; Noté et al.
2009). There were slight differences in the potency of
tested compounds, however none of them seemed to
be selective. In a study by Einbond et al., saponins
from Cimicifuga sp. were tested in two human breast
cancer lines, MDA-MB-453 (ER negative, Her2
overexpressing) and MCF-7 (ER positive, Her2
low). The latter cells were found much more resistant
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Table 2 Cytotoxic steroid saponins (2005–2009)
Source Saponoside Cell line Concentration Assay References
Agave utahensis
(Agavaceae)
IC50 [lg ml l
-1] MTT;
atiproliferative
Yokosuka
and
Mimaki
2009
(25R)-2b-hydroxy-5a-spirostan-3b-yl
O-b-D-Xyl-(1 ? 2)- O-b-D-Glc-
(1 ? 4)-b-D-Gal
HL-60 12.3
(25R)-5a-spirostan-3b-yl O-b-D-Glc-
(1 ? 2)-O-[b-D-Glc-(1 ? 3)]- O-b-
D-Glc-(1 ? 4)-b-D-Gal
9.4
(25R)-2a-hydroxy-5a-spirostan-3b-yl
O-b-D-Glc-(1 ? 2)-O-[b-D-Glc-
(1 ? 3)]- O-b-D-Glc-(1 ? 4)-b-D-
Gal
5.5
(25R)-2a-hydroxy-5a-spirostan-3b-yl
O-b-D-Glc-(1 ? 2)-O-b-D-Glc-
(1 ? 4)-b-D-Gal
11.3
Control: etoposide
0.20
(25R-5b-spirostan-3b-yl O-b-D-Glc–
(1?4)-b-D-Gal
4.90 Yokosuka
et al.
(2009)
Allium leucanthum
(Alliaceae)
IC50 [lmol l
-1] Resazurin
reduction;
antiproliferative
Mskhiladze
et al.
(2008)
Yayoisaponin A549 3.7
DLD-1 5.6
WS1 3.0
Eruboside B A549 5.3
DLD-1 8.2
WS1 3.6
Aginoside A549 5.8
DLD-1 7.9
WS1 3.6
(25R)-5a-spirostane-3b,6b-diol 3-O-
b-D-Glc-(1 ? 2)-[b-D-Xyl-
(1 ? 3)]-b-D-Glc-(1 ? 4)-b-D-Gal
A549 9.0
DLD-1 13.0
WS1 3.1
Leucospiroside A A549 5.0
DLD-1 7.2
WS1 4.55
(25R)-5a-spirostane-2a,3b,6b-triol
3-O-b-D-Glc-(1 ? 2)-b-D-Glc-
(1 ? 4)-b-D-Gal
A549 22.0
DLD-1 22.0
WS1 14.5
(25R)-5a-spirostane-3b,6b-diol 3-O-
b-D-Glc-(1 ? 3)-b-D-Glc-(1 ? 2)-
[b-D-Glc-(1 ? 3)]-b-D-Glc-
(1 ? 4)-b-D-Gal
A549 7.8
DLD-1 8.9
WS1 7.7
Control: etoposide
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
A549 1.1
DLD-1 4.8
WS1 Not determined
Control: 5-fluorouracil
A549 48.0
DLD-1 11.0
WS1 20.01
Allium
macrostemon
(Alliaceae)
IC50 [lmol l
-1] MTT; cytotoxic Chen et al.
(2009)
26-O-b-D-Glc-5a-furost-25(27)-ene-
3b,12b,22,26-tetraol 3-O-b-D-Glc-
(1 ? 2)-[b-D-Glc-(1 ? 3)]-b-D-
Glc-(1 ? 4)-b-D-Gal
SF-268 35.2
26-O-b-D-Glc-5b-furost-20(22)-
25(27)-dien-3b,12b,26-triol 3-O-b-
D-Glc-(1 ? 2)-b-D-Gal
NCI-H460 25.7
SF-268 35.4
Allium ursinum
(Alliaceae)
A mixture of: 2 lg ml-1 Trypan Blue Sobolewska
et al.
(2006)
(25R)-spirost-5-en-3b-ol 3-O-a-L-Rha-
(1 ? 4)-a-L-Rha-(1 ? 4)-[a-L-Rha-
(1 ? 2)]-b-D-Glc
B16 (100% dead cells) Exclusion;
and XC (100% dead cells) cytotoxic
(25R)-spirost-5,25(27)-dien-3b-ol
3-O-a-L-Rha-(1 ? 4)-a-L-Rha-
(1 ? 4)-[a-L-Rha-(1 ? 2)]-b-D-Glc
Anemarrhena
asphodelodes
(Liliaceae)
IC50 [lg ml
21] MTT; cytotoxic Bao et al.
(2007)
Sarsapogenin HepG2 42.4 (48 h)
25.0 (72 h)
Asparagus filicinus
(Asparagaceae)
IC50 [lg ml
21] SRB; cytotoxic Zhou et al.
(2007)
Filiasparoside A A549 13.3
MCF-7 11.2
Filiasparoside B A549 16.4
MCF-7 16.8
Filiasparoside C A549 2.3
MCF-7 3.0
Filiasparoside D A549 2.4
MCF-7 10.3
Aspafilioside A A549 9.4
MCF-7 [20
Aspafilioside B A549 7.6
MCF-7 10.4
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
A549 Control: etoposide
0.8
MCF-7 2.8
Asparagus
officinalis
(Asparagaceae)
Asparanin A HepG2 IC50 [lmol l
-1] MTT; cytotoxic Liu et al.
(2009a)
6.20 (24 h)
4.11 (48 h)
2.90 (72 h)
Asparagus
officinalis
(Asparagaceae)
IC50 [lmol l
-1] MTT; cytotoxic Huang et al.
(2008c)
(25S)-5b-spirostan-3b-ol 3-O-b-D-
Glc-(1 ? 2)-b-D-6-O-acetyl-Glc
A2780 10.57
MGC-803 8.39
CNE 5.50
Asparagoside A A2780 10.22
HO-8910 5.04
(25R)-5b-spirostan-3b-ol 3-O-b-D-Glc HO-8910 24.83
L1210 12.33
Sarsasapogenin A2780 6.09
(25S)-neospirost-4-en-3-one A2780 18.85
Eca-109 2.91
(25S)-5b-spirostan-3b-ol 3-O-b-D-
Glc-(1 ? 2)-[b-D-Xyl-(1 ? 4)]-
b-D-Glc
LTEP-a-2 2.85
KB 2.66
L1210 1.46
(25S)-5b-spirostan-3b-ol 3-O-b-D-
Glc-(1 ? 2)-b-D-Glc
Eca-109 4.03
MGC-803 3.72
LTEP-a-2 3.16
KB 1.38
L1210 4.32
(25S)-5b-spirostan-3b-ol 3-O-a-L-
Rha-(1 ? 2)-[a-L-Rha-(1 ? 4)-
b-D-Glc]
Eca-109 10.15
CNE 12.88
Control: doxorubicin
A2780 0.15
HO-8910 1.45
Eca-109 0.36
MGC-803 0.72
CNE 0.58
LTEP-a-2 1.33
KB 0.43
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
L1210 0.26
Asparagus
oligoclonos
(Asparagaceae)
IC50 [lg ml
21] SRB; cytotoxic Kim et al.
(2005)
Asparanin A A549 2.05
SK-OV-3 2.43
SK-MEL-2 2.41
XF498 2.56
HCT15 2.47
Aspaoligonin A A549 2.25
SK-OV-3 2.66
SK-MEL-2 2.53
XF498 2.84
HCT15 2.59
Aspaoligonin B A549 2.55
SK-OV-3 2.73
SK-MEL-2 2.59
XF498 2.51
HCT15 2.57
Control: adriamycin
A549 0.004
SK-OV-3 0.18
SK-MEL-2 0.03
XF498 0.012
HCT15 0.08
Balanites
aegyptiaca
(Balanitaceae)
IC50 [lmol l
-1] MTT; cytotoxic Gnoula et al.
(2008)
A mixture of balanitin-6 and
balanitin-7
A549 0.3
U373 0.5
PC-3 0.9
Bx-PC3 1.2
LoVo 1.5
MCF-7 2.6
Control: oxaliplatin
A549 3.9
U373 3.3
PC-3 9.2
Bx-PC3 [10.0
LoVo 4.7
MCF-7 8.9
Control: etoposide
A549 3.1
U373 1.4
PC-3 [10.0
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
Bx-PC3 [10.0
LoVo 4.9
MCF-7 [10.0
Control: 7-ethyl-10-
hydroxycamptothecin
A549 0.04
U373 0.001
PC-3 0.2
Bx-PC3 0.07
LoVo 0.4
MCF-7 0.03
Control: Taxol
A549 0.009
U373 0.001
PC-3 0.002
Bx-PC3 0.003
LoVo 0.005
MCF-7 0.001
Chlorophytum
borivilianum
(Liliaceae)
Borivilianoside H IC50 [lmol l
-1] MTT; cytotoxic Acharya
et al.
(2009)
HT-29 2.6
HCT 116 0.38
Control: paclitaxel
HT-29 3.6 9 10-3
HCT 116 1.1 9 10-3
Dioscorea
bulbifera
(Dioscoreaceae)
Pennogenin-3-O-a-L-Rha-(1 ? 3)-[a-
L-Rha-(1 ? 2)]-b-D-Glc
Bel-7402 10 lmol l-1 (99.1%
inhib.)
MTT;
antiproliferative
Liu et al.
(2009a)
SMMC7721 IC50 4.54 lmol l
-1
Pennogenin-3-O-a-L-Rha-(1 ? 4)-[a-
L-Rha-(1 ? 2)]-b-D-Glc
Bel-7402 10 lmol l-1 (92.6%
inhib.)
SMMC7721 IC50 4.85 lmol l
-1
Dioscorea villosa
(Dioscoreaceae)
IC50 [lmol l
-1] MTT;
antiproliferative
Hu et al.
(2007)
(25R)-spirost-5-en-3b-ol 3-O-a-L-Rha-
(1 ? 2)-O-[b-D-Glc-(1 ? 4)]-b-D-
Glc
HepG2 9.02
HEK293 13.21
MCF7 16.74
Paris polyphylla
(Liliaceae)
IC50 [lmol l
-1] MTT; cytotoxic Siu et al.
(2008)
Polyphyllin D NCI-H460 3.0
SF-268 3.0
Hep G2 3.5
HeLa 3.7
MCF-7 3.7
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
HEK-293 11.0
Control: cisplatin
NCI-H460 25
SF-268 15.6
Hep G2 20.2
HeLa 11.6
MCF-7 19
HEK-293 [100
Paris polyphylla
var. chinensis
(Liliaceae)
2.5 lg ml-1 MTT; cytotoxic Yun et al.
(2007)
Diosgenin-3-O-a-L-Rha-(1 ? 2)-O-
b-D-Glc
HepG2 60.59% dead cells
SGC7901 70.14% dead cells
BxPC3 76.52% dead cells
Pennogenin-3-O-a-L-Rha-(1 ? 2)-
O-b-D-Glc
HepG2 44.22% dead cells
SGC7901 50.13% dead cells
BxPC3 73.32% dead cells
Diosgenin-3-O-a-L-Rha-(1 ? 2)-
[a-L-Ara-(1 ? 4)]-b-D-Glc
HepG2 83.76% dead cells
SGC7901 88.19% dead cells
BxPC3 87.06% dead cells
Pennogenin-3-O-a-L-Rha-(1 ? 2)-
[a-L-Ara-(1 ? 4)]-b-D-Glc
HepG2 65.22% dead cells
SGC7901 70.39% dead cells
BxPC3 79.64% dead cells
Diosgenin-3-O-a-L-Rha-(1 ? 2)-
[b-D-Glc-(1 ? 3)]-b-D-Glc
HepG2 68.35% dead cells
SGC7901 77.34% dead cells
BxPC3 76.63% dead cells
Diosgenin-3-O-a-L-Rha-(1 ? 4)- a-L-
Rha-(1 ? 4)-[a-L-Rha-(1 ? 2)]-b-
D-Glc
HepG2 61.70% dead cells
SGC7901 75.81% dead cells
BxPC3 82.92% dead cells
Pennogenin-3-O-a-L-Rha-(1 ? 4)- a-
L-Rha-(1 ? 4)-[a-L-Rha-(1 ? 2)]-
b-D-Glc
HepG2 35.75% dead cells
SGC7901 47.58% dead cells
BxPC3 81.77% dead cells
Control: epirubicin-
HCl
HepG2 78.89% dead cells
SGC7901 70.73% dead cells
BxPC3 65.78% dead cells
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
Paris polyphylla
var. yunnanensis
(Liliaceae)
IC50 [lmol l
-1] MTT; cytotoxic Yan et al.
(2009)
Diosgenin-3-O-a-L-Ara-(1 ? 4)-
[a-L-Rha-(1 ? 2)]-b-D-Glc
LA795 1.85
Pennogenin-3-O-a-L-Ara-(1 ? 4)-
[a-L-Rha-(1 ? 2)]-b-D-Glc
5.14
Diosgenin-3-O-a-L-Rha-(1 ? 4)-
[a-L-Rha-(1 ? 2)]-b-D-Glc
3.06
Pennogenin-3-O-a-L-Rha-(1 ? 4)-
[a-L-Rha-(1 ? 2)]-b-D-Glc
2.26
Diosgenin-3-O-a-L-Rha-(1 ? 4)-
[a-L-Rha-(1 ? 4)]-[a-L-Rha-
(1 ? 2)]-b-D-Glc
1.35
Paris polyphylla
var. yunnanensis
(Liliaceae)
IC50 [lg ml
21] MTT; cytotoxic Zhao et al.
(2009)
Pennogenin-3-O-a-L-Ara-(1 ? 4)-
[a-L-Rha-(1 ? 2)]-b-D-Glc
HL-60 0.51
Tg 0.30
Tb 1.72
Pennogenin-3-O- b-D-Glc-(1 ? 3)-
a-L-Rha-(1 ? 2)]-b-D-Glc
3.75
Pa 0.18
Pb 0.14
Gracillin 0.53
Prosapogenin A of dioscin 0.38
Reclinatoside 0.52
Loureiroside 0.72
Control: cis-
diamminedichloro-
platinum
0.038
Polygonatum
punctatum
(Liliaceae)
IC50 [lg ml
21] MTT; cytotoxic Yang and
Yang
(2006)
Polypunctoside A HeLa 39.8
Polypunctoside B 3.2
Polypunctoside C 2.5
Polypunctoside D 2.6
Dioscin 20.4
Control: cisplatin
0.75
Sansevieria
ehrenbergii
(Agavaceae)
GI50 [lg ml
21] SRB;
antiproliferative
Pettit et al.
(2005)
Sansevistatin 1 P388 1.6
BXPC-3 1.1
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
MCF-7 1.1
SF-268 1.3
NCI-H460 0.43
KM20L2 0.47
DU-145 1.0
Sansevistatin 2 P388 1.7
BXPC-3 0.93
MCF-7 0.62
SF-268 0.68
NCI-H460 0.26
KM20L2 0.22
DU-145 0.42
Dioscin P388 1.5
BXPC-3 1.1
MCF-7 1.6
SF-268 1.2
NCI-H460 1.6
KM20L2 1.6
DU-145 1.6
3b-O-[a-L-Rha-(1 ? 2)]-b-D-Glc-
(25R)-spirost-5-ene
P388 1.5
BXPC-3 1.8
MCF-7 2
SF-268 1.8
NCI-H460 1.8
KM20L2 1.7
DU-145 1.6
3b-O-[a-L-Rha-(1 ? 2)]-[b-D-Xyl-
(1 ? 4)]- b-D-Glc-(25R)-spirost-
5-ene
P388 2.6
BXPC-3 1.7
MCF-7 1.4
SF-268 1.3
NCI-H460 1.2
KM20L2 0.5
DU-145 1.1
Solanum nigrum
(Solanaceae)
IC50 [lmol l
-1] MTT; cytotoxic Zhou et al.
(2006)
Degalactotigonin HepG2 0.25
NCI-H460 4.49
MCF-7 1.57
SF-268 3.19
Control: 10-hydroxy-
camptothecine
HepG2 6.49
NCI-H460 38.55
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Table 2 continued
Source Saponoside Cell line Concentration Assay References
MCF-7 19.12
SF-268 29.88
Solanum torvum
(Solanaceae)
IC50 [lg ml
21] MTT; cytotoxic Lu et al.
(2009)
Yamogenin-3-O- b-D-Glc-(1 ? 6)-
b-D-Glc
MGC-803 25.2
HepG2 32.7
AS49 34.2
MCF-7 29.4
Neochlorogenin-3-O- b-D-Glc-
(1 ? 6)-b-D-Glc
MGC-803 57.5
HepG2 65.5
AS49 58.3
MCF-7 48.4
Control: cis-diammine-
dichloroplatinum
MGC-803 14.4
HepG2 13.2
AS49 14.1
MCF-7 15.3
Tribulus
parvispinus
(Zygophyllaceae)
IC50 [lmol l
-1] Acid phosphatase
assay;
Perrone
et al.
(2005)
(25R)-26-O-b-D-Glc-5a-furostan-
3b,22a,26-triol 3-O-{b-D-Gal-
(1 ? 2)-O-[b-D-Xyl-(1 ? 3)]-O-
b-D-Glc-(1 ? 4)-b-D-Gal}
U937 0.5
Gitonin U937 0.1 WST1; cytotoxic
MCF-7 3.0
HepG2 3.0
Control: resveratrol
U937 17.0
MCF-7 100
HepG2 50
Tupistra chinensis
(Liliaceae)
10 lg ml-1 MTT;
antiproliferative
Zou et al.
(2006a)
Fraction containing: HeLa (81% inhib.)
(25S)-26-O-(b-D-Glc)-furost-5-en-
3b,22a,26-triol 3-O- b-D-Glc-
(1 ? 2)-b-D-Glc-(1 ? 4)-b-D-Glc
and
(25R)-26-O-(b-D-Glc)-furost-5-en-
3b,22a,26-triol 3-O-b-D-Glc-
(1 ? 2)-b-D-Glc-(1 ? 4)-b-D-Glc
HL-60 (92% inhib.)
Ypsilandra
thibetica
(Liliaceae)
IC50 [lg ml
21] MTT; cytotoxic Xie et al.
(2009)
Ypsilandroside G K562 4.4
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to saponin treatment (Einbond et al. 2008). Another
interesting example is a study on the effect of avicin
D from Acacia victoriae on apoptosis (Zhang et al.
2008). It was observed on three lymphoma cell lines
(MJ, Hut78, HH) and on cells from patients with
Sézary syndrome. Moreover, cells from healthy
donors and two normal T-cell lines (CD4? and
activated CD4?) were used as comparative material.
Apoptosis was seen in all lymphoma cell lines and in
Sézary syndrome patient cells whereas only slight
apoptotic changes were detected in normal cells.
The study by Zhang et al. was well designed also in
another aspect, because the major drawback of cyto-
toxicity tests summarized in this review, is that only
few compare the effect on cancer cells with the effect
on normal cells. Thus, it is very hard to draw any
conclusions on the future potential of these compounds
as anticancer drugs because no data on their selectivity
are provided. One of worth noting recent examples is
the study by Tian et al. who tested triterpenoid saponins
isolated from Ardisia crispa against human glioblas-
toma U251MG cell line (Tian et al. 2009). While all the
four compounds exhibited significant cytotoxicity
against cancer cells (IC50 2.57–12.20 lmol l
-1)
they did not affect the growth of primary cultured
human astrocytes at concentrations as high as [100
lmol l-1.
The most preferred methods used for cytotoxicity
screening were MTT (formazan based assay) and SRB
(sulphorhodamine B assay), however in some studies
other techniques were also applied, like eg. neutral red
release assay. In rare cases, brine shrimp lethality test
is still applied even though it is rather unspecific.
According to Houghton et al. the SRB assay is more
sensitive and rapid than MTT, which was more
popular among authors of studies cited in Tables 1
Table 2 continued
Source Saponoside Cell line Concentration Assay References
Pennogenin-3-O-a-L-Rha-(1 ? 2)-[a-
L-Rha-(1 ? 4)- a-L-Rha-(1 ? 4)]-
b-D-Glc
SPC-A-1 6.3
BGC-823 6.9
Eca-109 8.0
AGS 8.9
K562 4.7
SPC-A-1 6.3
BGC-823 6.9
Eca-109 8.0
AGS 8.9
Control: cisplatin—
data not given
Cancer cell lines: Prostate: LNCaP, PC-3, DU-145; Leukemia: CEM, K562, HL60, *L1210, P388; Ovarian: SK-OV-3, A2780,
OVCAR3, HO-8910; Breast: MDA-MB-231, MCF-7, MDA-MB-453, MDA-MB-435; Lung: A-549, H522-T1, COR-L23, NCI-
H460, LTEP-a-2, *LA795, SPC-A-1; Melanoma: G361, MEL-5, A375, C32, *B16F1, *B16F10, SK-MEL-2, HTB-140; Colon:
HCT-15, HT-29, WiDr, HCT116, CaCo-2, SW1116, HCT-8, DLD-1, LoVo, KM20L2; Lymphoma: U937; Pharynx: CNE, KB, Eca-
109; Liver: HepG2, Huh-7D12, Bel-7402, Hepa59T/VGH, SMMC7721; Stomach: MGC-803, MKN-45, BGC-803, BGC823, KATO-
III, SGC7901, AGS; Pancreas: Bx-PC3; CNS: U251, SF268, *C6, U251MG, U373, Daoy, XF498; Renal: ACHN; Bone: 1547,
*WEHI-164, *XC, RPMI 8226; Uterus: HeLa
Normal cell lines: Fibroblasts: HSF, BJ-H-tert, 142BR, HFL-I, WS1; Macrophages: *RAW 264.7, *J774.A1; Epithelium/
endothelium: EVC-304, MCF-10A; Kidney embryonic: HEK-293; * Murine origin
Concentration: IC50 half maximal inhibitory concentration; ED50 effective dose; GI50 growth inhibition; LC50 lethal concentration;
LD50 lethal dose
Assays: MTT—3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; XTT—2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino) carbonyl]-2H-tetrazolium hydroxide; MTS—3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium; WST-1—2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium,
SRB—sulphorhodamine. PI—propidium iodide. NRR—neutral red release
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Fig. 1 Chemical structures
of polyphyllin D (1), methyl
protodioscin (2), albizoside
C (3) and saponin PE (4)
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and 2 (Houghton et al. 2007). There may be some
minute differences in IC50 values obtained with these
methods (Dongre et al. 2007).
In the majority of cases IC50 values were com-
pared with a control. Usually, the reference substance
was a known, clinically used anticancer agent, like
etoposide, paclitaxel, doxorubicin, adriamycin, cis-
platin, in some cases however, compounds still under
investigation like betulinic acid (Cmoch et al. 2008)
or resveratrol (Perrone et al. 2005) were applied.
Sometimes, information on the use of a positive
control was not accompanied by IC50 data (Xie et al.
2009; Cao et al. 2007).
As can be seen from comparison of IC50 values
(Tables 1, 2) most saponins, both triterpenoid and
steroid, were less active than the reference com-
pounds. In some cases, however, their cytotoxicity
was comparable or even higher. Among triterpenoid
saponins, acylated oleanane-type glochierioside A,
was cytotoxic against HL-60, MCF-7, SK-OV-3 and
HT-29 cell lines with IC50 values similar to mitoxan-
trone (Kiem et al. 2009). One of the structurally
related acylated oleanane-type albizosides, albizoside
C (Fig. 1) isolated from Albizia chinensis, was more
potent than camptothecin on five cell lines, the
difference was especially notable against lung car-
cinoma A549, with IC50 0.01 lmol l
-1 vs.
3.1 lmol l-1 (Liu et al. 2009b). Other examples
worth noting are holostane saponins from a sea
cucumber Pseudocolochirus violaceus, which exhib-
ited distinctly higher cytotoxicity than 10-hydroxy-
camptothecin used as a positive control against
colon cancer HCT-116 (IC50 0.052–0.066 and
0.135 lmol l-1, respectively) (Zhang et al. 2007).
Among steroid saponins, the activity of filiasparoside
C (Asparagus filicinus) against MCF-7 was compa-
rable to etoposide (IC50 3.0 and 2.8 lg ml
-1, respec-
tively) (Zhou et al. 2007). Also, similar levels of cell
growth inhibition were observed for diosgenin-3-O-a-
L-Rhap-(1 ? 2)-[a-L-Araf-(1 ? 4)]-b-D-Glcp and
control epirubicin-HCl against HepG2, SGC7901
and BxPC3 (Yun et al. 2007). Degalactotigonin from
Solanum nigrum exhibited much higher cytotoxicity
than 10-hydroxycamptothecin on a panel of four cell
lines (HepG2, MCF-7, SF-268, NCI-H460) with
IC50 values ranging from 0.25–4.49 and 6.49–
38.55 lmol l-1, respectively (Zhou et al. 2006).
Comparison of cytotoxicity level is, however, only
an approximation as there are notable differences in
IC50 values between control compounds, for example
IC50 of etoposide against A549 was 1.1 lmol l
-1
whereas IC50 of 5-fluorouracil against the same cell
line was as high as 48 lmol l-1 (Mskhiladze et al.
2008). Gnoula et al. in their study of cytotoxic
activity of a mixture of balanitin-6 and balanitin-7
against a panel of six cell lines (A549, U373, PC-3,
Bx-PC3, LoVo, MCF-7) compared IC50 values with
as much as four reference substances: oxaliplatin,
etoposide, 7-ethyl-10-hydroxycamptothecin and pac-
litaxel (Gnoula et al. 2008). The tested saponin
mixture was significantly more active (IC50 from 0.3
to 2.6 lmol l-1) than oxaliplatin (IC50 from 3.3 to
[10 lmol l-1) but significantly less active than
paclitaxel (IC50 from 0.001 to 0.009 lmol l
-1). Thus,
a choice of reference may lead to various conclusions
with respect to the potency of cytotoxic compounds.
Most often, IC50 values for paclitaxel are of
nmol l-1 order whereas for saponins in the same cell
line—lmol l-1. It is interesting to note that one of
triterpene saponins isolated from Gordonia chrysan-
dra (Theaceae)—gordonoside C, was significantly
more potent than paclitaxel against Bel-7402 (IC50
0.7 and 6.3 lmol l-1, respectively) (Yu et al. 2009).
Another issue worth mentioning with respect to
cytotoxicity values presented in Tables 1 and 2 is that
there is often no obvious correlation between the in
vitro and in vivo effects, therefore compounds of
lesser activity might prove more valuable when tested
in animal models. A good example is provided by the
study of Bang et al. An oleanolic acid saponin which
was most active in vitro had an inferior in vivo
antitumor activity, contrary to a hederagenin glyco-
side (Bang et al. 2005).
Bioavailability would be an important aspect to
discuss in this respect and more studies are certainly
needed as only limited data are available in the
literature with regard to the pharmacokinetics and
bioavailability of saponins both triterpene and steroi-
dal. Most of the available data indicate that these
compounds are very poorly absorbed following oral
administration to animals and humans. As these
issues are outside the scope of the present review,
only examples of reports which refer to saponins with
cytotoxic or anti-tumor activities are presented.
In the study by Li et al., it was shown that the
absolute bioavailability of dioscin after oral admin-
istration to rats was very low (0.2%). Dioscin
underwent a prolonged absorption from the
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intestines, its level in the intestine remained quite
high even after 120 h after administration (Li et al.
2005). Similar results were obtained in the study by
Ren et al. The 3H labeled total saponins of Dioscorea
nipponica (including dioscin, pseudoprotodioscin,
protodioscin and methyl protodioscin) were orally
administered (80 mg kg-1) to rats. The compounds
were found to have a long half-life in rats. The
highest emission of radioactivity level at the 120th h
was measured in the liver, adrenal gland, and walls of
the gastrointestinal tract. The blood concentration of
3H labeled compounds was very low (Ren et al.
2008).
He et al. concluded that oral bioavailability of
methyl protodioscin in rat (80 mg kg-1) was good.
Ten metabolites of the parent compound, including
dioscin, were identified in the urine. Some of them
showed potent antiproliferative activities towards
HepG2, NCI-H460, MCF-7 and HeLa human cell
lines, but their cytotoxic effects were much weaker in
comparison to methyl protodioscin activity (He et al.
2006).
Amongst triterpene saponins, tubeimoside I, iso-
lated from the tubers of Bolbostemma paniculatum
which has gained much attention due to its antitumor
and antitumor-promoting effects, has been examined
in order to assess pharmacokinetics and bioavailabil-
ity after intravenous and oral administration to rats.
Its oral bioavailability (50 mg kg-1) was only 0.23%
which indicated poor absorption or acid-induced
degradation (Liang et al. 2007).
However, there were also reports which proposed
new strategies to increase absorption of such amphi-
philic compounds as saponins. In studies on ginseng
saponins it was suggested that worse permeability
from gastrointestinal tract may be due to surface
activity of saponins which might self-assemble as
micelles in solution. Such micellar aggregates would
have an increased molecular size and hydrophyllic
property and thus result in poor permeability. To prove
that this suggestion holds true Xiong et al. designed a
lipid-based formulation that was expected to prevent
ginsenosides from aggregation and then compared the
relative bioavailability of ginsenosides Rg1 and Rb1
from an aqueous solution and this new formulation.
After intraduodenal administration of the new formu-
lation ginsenoside bioavailability in rats was remark-
ably enhanced relative to the aqueous solution
(AUC0- of Rg1 and Rb1 were 207.52 ± 53.95 and
1,961.72 ± 686.60 lg ml-1 h compared to 7.87 ±
2.85 and 148.58 ± 36.73 lg ml-1 h). (Xiong et al.
2008).
Another interesting example that shows how by
modifying a drug’s formulation its bioavailability may
be enhanced is a study of Gu et al. on beagle dogs. The
authors compared oral bioavailability of anti-tumor
20(R)-ginsenoside Rh2 and its micronized formulation.
The results obtained indicated that the bioavailability
of oral micronized 20(R)-Rh2 was almost two-fold
higher than that of native ginsenoside (AUC0-
2375.9 ± 882.5 and 1,215.7 ± 598.6 ng ml-1 h,
respectively; Cmax 730.0 ± 325.5 and 371 ± 199.6
ng ml-1, respectively; Tmax 1.8 ± 0.7 and 2.6 ±
1.3 h, respectively). The authors concluded that Rh2
in the micro-particle formulation seems to be better
dissolved in the intestinal juice and transported across
the intestinal epithelial cells (Gu et al. 2006).
Correlation between the structure and cytotoxicity
of saponins
Observations from numerous studies confirm that the
biological activity of saponins is influenced both by
the aglycone and the sugar moiety. Most existing
information of the structure-activity relationships
comes from research on the haemolytic action of
saponins. As was shown for triterpenoid and steroid
compounds there are certain structural features which
seem to influence the strength of the lysis of
erythrocytes, however, it is hardly possible to estab-
lish any uninamous correlation. In the case of
triterpene saponins for example, acylation seems to
be beneficial in terms of their haemolytic potential
(Melzig et al. 2001; Chwalek et al. 2004), for steroid
saponins most studies conclude that furostanols are in
general inactive. Similarly, the nature of carbohy-
drate constituents influences haemolytic action of
both types of saponins but this effect is not repeatable
with the same sugar moiety and a different aglycone.
The lysis of erythrocytes is one of the most
characteristic biological features of saponins and is
considered as a major drawback in their clinical
development. As was mentioned earlier, it is believed
to result mainly from the ability of these compounds
to interact with membrane cholesterol leading to
membrane destabilization but not only (Francis et al.
452 Phytochem Rev (2010) 9:425–474
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2002; Melzig et al. 2001). The same mechanism is
also involved in the cytotoxicity of saponins how-
ever, as was shown in many studies, a large number
of compounds act via different modes of action,
including apoptotic and non-apoptotic cell death
inducement, which are also reviewed in this paper.
Comparison of the steroidal saponins haemolytic
activity with their cytotoxicity revealed that these two
activities were not correlated because of different
mechanisms of action (Wang et al. 2007). It was
observed however, that some highly haemolytic
compounds were highly cytotoxic as well, and
similarly some weakly toxic steroidal saponins had
weak haemolytic activity. At the same time, several
glycosides showing similar cytotoxicity had disparate
haemolytic activity and opposite, some compounds
possessing comparable haemolysis potency had dis-
parate cytotoxicity. Therefore, there is no clear
correlation between the haemolytic activity and
cytotoxicity of steroidal saponins and similarly the
SAR data referring to haemolysis cannot be directly
extrapolated to relationships crucial for cytotoxic
activity.
While most studies in which cytotoxic activity of
saponins is reported focus on structure elucidation
there are sparse data, if any, on SAR relevant to
cytotoxicity results, which are often published as
additional information accompanying structure eluci-
dation procedures. Some information is usually pro-
vided by authors who isolate, from a given plant
source, a greater variety of structures. However, there
is still a fairly limited number of comparative studies
which directly concentrate on establishment of struc-
ture-activity relationships relevant to cytotoxicity.
Several studies which explored the correlation
between haemolytic activity and cytotoxicity of
saponins have been published, the most recent are
the reports by Gauthier et al. on triterpenoid glyco-
sides and by Wang et al. on steroid saponins
(Gauthier et al. 2009a; Wang et al. 2007). Most
crucial structure-cytotoxic activity relationships are
summarized in Table 3.
Correlation between the structure and cytotoxicity
of triterpenoid saponins
The most recent SAR study by Gauthier et al.
compared the effect on haemolysis, cytotoxicity and
membrane cell permeabilization of 35 semi-synthetic
and natural triterpenoid saponins (Gauthier et al.
2009a). In their previous work (Gauthier et al. 2006),
the authors investigated only lupane-type compounds,
this extended study encompassed compounds with
lupane and oleanane skeleton The authors subdivided
the tested compounds into five groups: free triterp-
enoids such as betulin, betulinic acid, hederagenin
and oleanolic acid; lupane monodesmosides (with
a-L-Rhap, a-L-Araf, a-D-Manp, b-D-Glcp, b-D-Galp,
b-D-Xylp); lupane bidesmosides (with a-L-Rhap and
b-D-Glcp or a-L-Rhap); lupane saponins containing
a-L-arabinopyranose (mono and bidesmosides with
either a-L-Rhap or/and b-D-Glcp); oleanane saponins
(a-hederin, b-hederin, d-hederin, hederacolchiside A
and hederacolchiside A1). Human cell lines assessed
in this study included lung carcinoma A549, colo-
rectal adenocarcinoma DLD-1 as well as normal skin
fibroblasts WS1.
Based on the obtained results the authors con-
cluded, that in the case of oleanane type saponins
those having oleanolic acid as an aglycone were more
potent than hederagenin saponins irrespective of the
sugar moiety. Again, this study confirms that as far as
sugar part is concerned it seems that the presence at
the C-3 position of the aglycone of an a-L-Rhap-
(1 ? 2)-a-L-Arap moiety is a structural requirement
essential for potent cytotoxic activity of oleanane
saponins.
What is worth noting is the fact, that the same
sugar sequence has no effect on the cytotoxicity of
lupane-type saponins, such compounds were inactive
even at the highest concentrations tested in this study
(IC50 [ 100 lmol l
-1) whereas the presence of the
sole a-L-Arap moiety had a significantly positive
effect. The cytotoxicity of betulin and betulinic acid
derivatives significantly varied according to the
nature of monosaccharides linked to C-3 and C-28.
In monodesmosidic compounds the most active were
a-L-rhamnopyranosides and in bidesmosidic saponins
those containing two rhamnose moieties. In fact,
betulin bis-3,28-a-L-rhamnopyranoside was the most
potent inhibitor of cell lines of all compounds tested,
with IC50 ranging from 1.3 to 1.9 lmol l
-1. How-
ever, this last saponoside was not selective towards
cancer cells. In this respect, the most promising was
betulinic acid a-L-rhamnopyranoside, which exerted
strong cytotoxicity on cancer lines with IC50 from 2.6
to 3.9 lmol l-1 while IC50 for human fibroblasts was
as high as 31 lmol l-1.
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With regard to the other monosaccharides evalu-
ated in this study, it seems that the presence of a b-D-
Glcp either at C-3 or C-28 has a detrimental effect on
the cytotoxicity of lupane-type saponins. The possi-
ble explanation of this phenomenon may be the high
polarity of the glucose moiety which might hinder the
diffusion of glucose bearing saponins into the cyto-
plasm. On the other hand, it was postulated that
rhamnose facilitates this process by its interaction
with lectins and thus, saponins bearing this sugar-unit
more easily enter the cell exerting anticancer action.
The presence of a rhamnose residue in the sugar
chain attached at C-3 as a feature responsible for
cytotoxicity was also pointed out by other reports
(Chang et al. 1998; Cham and Daunter 1990), and
more recently by Tabatadze et al. who studied the
Table 3 Structure-cytotoxic activity relationships of saponins
Structural feature Enhancement of activity References
Type of triterpene aglycone Oleanane [ lupane Bang et al. (2005)
Oleanane [ hopane Hamed et al. (2005)
Lupane [ germanicane Thibeault et al. (2007)
Oleanolic acid [ hederagenin in vitro Gauthier et al. (2009a), Bang et al. (2005)
Hederagenin [ oleanolic acid in vivo Bang et al. (2005)
Betulinic acid [ betulin Thibeault et al. (2007)
Oleanane-type aglycone Free carboxyl at C-28 Chwalek et al. (2006), Bang et al. (2005)
Acylation at C-21 and C-22 Zhang and Li (2007), Chan (2007), Chan et al. (2008),
Yu et al. (2009)
Oleanane-type aglycone acylated
at C-21 and C-22
Methyl at C-24 [ hydroxymethyl at
C-24
Chan et al. (2008)
Free hydroxyl at C-16 Yu et al. (2009)
13,28-epoxyoleanane-type
aglycone
Aldehyde/methyl at C-30 [ carboxyl/
hydroxymethyl at C-30
Tian et al. (2009)
Free hydroxyl at C-16 Chang et al. (2007)
Acacic acid-type aglycone Oligosaccharide ester at C-28 Cao et al. (2007)
Free hydroxyl at C-16 Cao et al. (2007)
Acylation at C-21 (monoterpene-
quinovopyranosyl moiety)
Cao et al. (2007), Noté et al. (2009), Liu et al. (2009b)
Oleanane-type saponins
Ursane-type saponins
Lupane-type saponins
Monodesmosides [ bidesmosides Calabria et al. (2008), Bang et al. (2005), Gauthier
et al. (2009a)
Acacic acid-type saponins Bidesmosides [ monodesmosides Zou et al. (2006b), Cao et al. (2007)
Oleanane-type saponins a-L-Arap at C-3 Jung et al. (2004), Chang et al. (2007)
a-L-Rhap-(1 ? 2)-a-L-Arap moiety at
C-3
Chwalek et al. (2006), Bang et al. (2005), Gauthier
et al. (2009a)
Branched trisaccharide at
C-3 [ disaccharide at C-3
Bang et al. (2005)
Straight chain length ? contradictory
data
Jung et al. (2004), Ahmed et al. (2009), Huang et al.
(2008b), Tundis et al. (2009)
Lupane-type saponins a-L-Rhap at C-3 Gauthier et al. (2009a)
Betulin saponins a-D-Manp at C-3 Thibeault et al. (2007)
Monomannosides [ bimannosides Cmoch et al. (2008)
Diosgenyl saponins a-L-Rhap-(1 ? 2)-b-D-Glcp at C-3 Mimaki et al. (2001), Hernández et al. (2008)
Elongation of sugar chain Yan et al. (2009)
Diosgenin and pennogenin
saponins
Terminal Rhap linked to C-2 of the
inner Glcp
Zhao et al. (2009)
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effect of giganteosides D and E on leukemia HL-60
and MEL-5 cell lines (Tabatadze et al. 2007).
Another observation from the study of Gauthier
et al. (2009a) is that haemolytic activity, membrane
cell permeabilization and cytotoxicity of oleanane-
type saponins seem to be directly correlated whereas
the cytotoxic action of lupane saponins does not
result from inducement of membrane permeabiliza-
tion and is due to another mechanisms.
In another SAR study by the same group with
synthetic triterpenoid glycosides of germanicane- and
lupane-type (Thibeault et al. 2007) the authors
concluded that: (1) germanicane-type saponins are
weaker anticancer agents than lupane-type com-
pounds, (2) betulinic acid saponins generally exert
higher in vitro cytotoxicity than those derived from
betulin, with the exception of betulin 3b-O-a-D-
mannopyranoside, (3) other sugars linked to the C3 of
betulin (D-glucose, L-rhamnose, D-arabinose, D-gal-
actose, D-xylose) supress anticancer activity.
Based on reports that mono- and trimannosyl
residues may be regarded a convenient means of
delivering drugs into human dendritic cells or mac-
rophages, Cmoch et al. synthesized a number of such
mannosylated derivatives of lupeol, betulin and
betulinic acid and compared their cytotoxic activity
(Cmoch et al. 2008). Cytotoxicity was assayed on
normal human fibroblasts (BJ-H-tert) and a panel of
cancer cells: T-lymphoblastic leukemia (CEM),
breast carcinoma (MCF-7), lung carcinoma (A-549),
multiple myeloma (RPMI 8226), cervical carcinoma
(HeLa), malignant melanoma (G361). The data
obtained from this study showed that the tested
lupane-type compounds selectively inhibit the growth
of cancer cells without affecting normal cells. With
regard to the sugar moiety, monomannosyl deriva-
tives of lupeol, betulinic acid and betulin were
strongly cytotoxic whereas trisaccharide analogues
were inactive.
Similar groups of saponins, that is of lupane-type
(eight compounds) and oleanane-type (nine com-
pounds) were evaluated by Bang et al. against human
solid tumors cell lines A-549, SK-OV-3, SK-MEL-2
and HCT-15 and also subjected to in vivo test (Bang
et al. 2005). The compounds were isolated from one
plant species, namely Pulsatilla koreana roots. Pre-
viously, one of the saponins from this plant species,
so called Pulsatilla saponin D (hederagenin 3-O-a-L-
rhamnopyranosyl-(1 ? 2)-[b-D-glucopyranosyl-
(1 ? 4)]-a-L-arabino-pyranoside) gained much inter-
est as it showed only moderate activity against cancer
cells in vitro whereas had a potent antitumor action
on a solid tumor in vivo (IR, 82%), which was higher
than adriamycin (IR, 64%) (Kim et al. 2004).
The results from a SAR study by Bang et al.
(2005) indicate that generally, the cytotoxicities of
the lupane-type saponins were much weaker than
those of oleananes, when an a-L-Rhap-(1 ? 2)-a-L-
Arap sequence was present in a branched sugar
moiety at C-3 of the aglycone. These results were in
agreement with those obtained by Gauthier (Gauthier
et al. 2009a) however sugar moieties in most
compounds evaluated by Bang et al. were composed
of more monosaccharide units. Another observation
concerning aglycone part, that the existence of a free
carboxyl at C-28 is important for antitumor activity,
conformed with some reports (Chwalek et al. 2006)
but was contradictory to other (Gauthier et al. 2009a)
who showed that some bidesmosidic betulinic acid
saponins glycosylated at C-28 were highly cytotoxic.
Moreover, comparison of activities exerted by sapo-
nins derived from oleanolic acid and hederagenin
made the authors postulate that the hydroxyl group at
C-23 has a negative effect on cytotoxicity.
The comparison of the relationship between the
structure of the sugar moiety and cytotoxic activity of
oleanane saponins was in agreement with other
reports (Gauthier et al. 2009a)—again the presence
of an a-L-Rhap-(1 ? 2)-a-L-Arap sequence at C-3
produced higher cytotoxicity. Moreover, trisaccha-
rides with a third sugar linked at C-40 of arabinose or
C-30 of rhamnose exhibited stronger cytotoxicities
than disaccharides.
A very interesting observation comes from in vivo
experiments, as no direct correlation was seen with in
vitro cytotoxicity. The main difference was in
oleanane aglycones—oleanolic acid derivatives
showing much stronger cytotoxicities in vitro than
those of hederagenin, had an inferior in vivo antitu-
mor activity. This may be due to the differences in
bioavailability of these structures, so the presence of
a hydroxyl at C-23 seems to be more effective for in
vivo antitumor activity. With regard to sugar moiety,
both the number of glucopyranosides and their
binding position to the active O-a-L-Rhap-(1 ? 2)-
a-L-Arap sequence is of importance for in vivo
effects. The authors postulate that this may be related
to the rate of glucose hydrolysis in the cell, the more
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glucose molecules in the chain the lower hydrolysis
rate. Moreover, the third glucopyranoside attached at
C-400 is more resistant to glucose-hydrolase than at
C-200 and thus, such a saponin can more effectively
reach the target site. So, it seems that a trisaccharide
chain O-a-L-Rhap-(1 ? 2)-[b-D-Glcp-(1 ? 4)]-a-L-
Arap is responsible for the improvement of the
bioavailability in tumor tissue in vivo. In a later study
by Bang (Bang et al. 2007), a method for simple
synthesis of this trisaccharide moiety was described.
Chwalek et al. examined structure-activity rela-
tionships of oleanane glycosides with cytotoxicity,
apoptosis induction and haemolysis (Chwalek et al.
2006). The tested saponins were 25 synthetic heder-
agenin derivatives including six methyl esters. The
authors focused mainly on determination of the
influence of the monosaccharide composition and
interglycosidic linkages within the sugar moieties
because they aimed at verification of the importance
of sugar chain. However, a comparison was also
made between compounds with a free or esterified
carboxyl at C-28. The compounds were divided into
two groups of hederagenin saponins, those containing
an a-L-arabinose or b-D-glucose as the first sugar as
well as their methyl esters. Moreover, saponins
having a non-naturally occurring b configuration
between the aglycone and L-arabinose were also
investigated. In the arabinose series, positional
disaccharide isomers bearing a-L-rhamnose, b-D-
xylose or b-D-glucose attached to positions 2, 3 or 4
were included in the study, whereas in the glucose
series, saponins with the following dissaccharide
residues were considered: cellobiosyl, lactosyl,
maltosyl, gentiobiosyl, isomaltosyl and melibiosyl.
Cytotoxicity was tested on KB cells with SN 38 as a
positive control.
As far as the sugar moiety is concerned, the
following observations were made. Saponins having a
non-natural anomeric configuration of b-L- or a-D-
were inactive or only slightly active. Glucose at the
first position of the disaccharide chain is unfavorable
for cytotoxic activity when compared to arabinose.
Neither the nature of the second sugar nor the
interglycosidic linkages are in themselves determi-
nant as each sugar can affect cytotoxicity when at a
specific position. Thus, for an a-L-rhamnose the
following order of activity was established
(1 ? 2) [ (1 ? 3) [ (1 ? 4) and for b-D-xylose
(1 ? 2) [ (1 ? 4) [ (1 ? 3). The most potent
saponin was a-hederin. This fact provided further
evidence that the a-L-Rhap-(1 ? 2)-a-L-Arap osidic
sequence is essential for the cytotoxic activity of
hederagenin glycosides.
As far as aglycone is concerned, esterification in
position 28 generally decreased cytotoxicity. It is
interesting to note that haemolytic activity was
increased in the majority of cases what supports
previous observations that it is impossible to correlate
haemolytic and cytotoxic activities of saponins.
In another SAR study (Jung et al. 2004) oleanane
disaccharides isolated from Akebia quinata were
evaluated against the same human cell lines as those
used in the study by Bang et al., that is lung cancer
A549, ovarian cancer SK-OV-3, melanoma SK-
MEL-2, colon cancer HCT-15 and in addition brain
tumor XF498. Cytotoxicity against normal human
cells was not evaluated. The study included a more
limited number of compounds—six saponins with
oleanolic acid or hederagenin as aglycones and with
a-L-Arap as the first sugar attached to the sapogenin.
The authors suggested that cytotoxicity of saponins is
predominantly due to the sugar moiety as the effects
of the two compounds with the same sugar sequence
were very similar. Moreover, comparison of saponins
with a different linkage position between monosac-
charides, namely 1 ? 2 and 1 ? 3, showed, that
these linkages are not crucial for cytotoxicity.
However, the nature and linkage of the second sugar
is of importance, rhamnose manifested more potent
activity than glucose, and axially attached 40-O-b-D-
glucosyl was the least effective. Also, elongation
of the sugar chain had a detrimental effect on
cytotoxicity.
This last observation seems to need further con-
firmation as there are also reports with contradictory
data. For example, in another study on hederagenin
saponins (isolated from Duranta repens) those with
four sugar units exhibited greater cytotoxicity than
those possessing three sugars (Ahmed et al. 2009),
however these differences were seen on only one cell
line—HepG2. Same effects were noted when com-
paring cytotoxic activity of seven oleanane-type
saponins (hydrocosisaponins A-F and hydrocotylo-
side VII) from a Chinese folk medicinal plant
Hydrocotyle sibthorpioides (Huang et al. 2008b).
Compounds with four sugar units, three D-glucoses
and one L-arabinose, were much more active than
those depleted of a terminal glucose.
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On the other hand, cytotoxicity assay performed
on a wider panel of human cell lines (malignant
melanoma A375, amelanotic melanoma C32, Cauca-
sian lung carcinoma A549, hepatocellular carcinoma
Huh-7D12, Caucasian lung large cell carcinoma
COR-L23, Caucasian colon adenocarcinoma CaCo-
2, prostate carcinoma LNCaP, renal adenocarcinoma
ACHN, breast cancer MCF-7, skin fibroblast 142BR)
of two saponins sharing the same aglycon, buddleja-
saponin IV and songarosaponin D but differing in the
sugar chain length (two glucoses ? fucose; three
glucoses ? fucose, respectively) does not indicated
any general influence of this structural feature on the
cytotoxicity. Compound with three monosaccharides
was much more active than saponin bearing a four-
sugar chain against ACHN cells (IC50 7.9 lmol l
-1
vs. 37.2 lmol l-1) whereas it was much weaker
against CaCo-2 cells (IC50 40.7 lmol l
-1 vs.
16.7 lmol l-1) (Tundis et al. 2009).
Calabria et al., in their study on the effects on
cancer cells proliferation of nine oleanene- and
ursene-type saponins from Silphium radula, also
observed that the length and linkage of the sugar
chain influences cytotoxicity. Moreover, the authors
suggested that a monodesmosidic disaccharide chain
containing a galactopyranosyl residue produces
higher activity than bidesmosidic or monodesmosidic
single sugar moiety (Calabria et al. 2008).
In a cytotoxicity assay of dammarane saponins on
human breast cancer MCF-7 cell line it was shown
that the number of glycosyls affects the activity of
ginsenosides, those with one glycosyl are more potent
than those bearing three or four glycosyls (Qiu et al.
2009). In this study ginsenoside Rh2 was used as a
positive control (IC50 20 lmol l
-1). In another study
on dammarane-type saponins, it was concluded that
the number of hydroxyl groups in the side-chain plays
a crucial role in their cytotoxicity, two hydroxyls
being more beneficial than one or three (Huang et al.
2008a).
Zhang and Li screened five pre-selected saponins
isolated from Aesculus pavia against a panel of 59
cell lines from nine human cancers: leukemia, non-
small cell lung, colon, CNS, melanoma, ovarian,
renal, prostate and breast. These saponins were
polyhydroxyoleanenes with or without acyl groups
at C-21 and/or C-22 and a sugar moiety composed of
a-L-Araf, b-D-GlcAp, b-D-Galp. From the results
obtained with a large array of cancer cell lines it
seems that the presence of two acyl groups is
important for cytotoxicity as non-acylated saponins
showed no or only weak activity (Zhang and Li
2007).
This observation conformed with other reports, for
example on saponins isolated from Xanthoceras
sorbifolia (Chan 2007). Structure-activity relationship
study was performed on an oleanane-type compound
Xantifolia-Y, the characteristic features of which are
diangeloyl groups at C-21 and C-22 and a trisaccharide
chain at C-3 composed of (-[b-D-galactopyranosyl-
(1 ? 2)]-a-L-arabinofuranosyl-(1 ? 3)-b-D-glucur-
onopyranosyl). For the purpose of the SAR study,
angeloyl groups or sugar moiety were separately
removed and thus obtained derivatives together with
b-escin and xantifolia-X (saponin with one angelolyl at
C-22) were comparatively assayed against ovarian
cancer cells OVCAR3. Moreover, effect on haemol-
ysis was also evaluated. Based on the obtained results it
was concluded that while removal of the sugar moiety
significantly decreases both cytotoxicity and haemo-
lytic activity the removal of angelolyls at C-21 and
C-22 completely eliminates these activities. It seems
also that acylation with angelolyl group increases
cytotoxicity when compared to acetyl group.
In this study by Chan a very limited number of
compounds were compared versus only one cell line,
however in a later report (Chan et al. 2008) six more
saponins were evaluated. Again it was confirmed that
acylation at both C-21 and C-22 increases cytotox-
icity, and moreover it was postulated that analogues
with a C-24 methyl group (instead of CH2OH) and a
galactose unit (instead of glucose) in the trisacharide
moiety at C-3 exhibit higher potency.
Seven structurally related oleanane-type saponins
with diangeloyl groups at C-21 and C-22, additional
oxygenated substituents at C-15 and/or C-16, and a
disaccharide chain at C-3 isolated from Gordonia
chrysandra were evaluated against a wider panel of
human cancer cell lines (HCT-8, Bel-7402, BGC-
823, A549 and A2780) (Yu et al. 2009). The obtained
results indicated that a free hydroxyl at C-16 may be
of importance in mediating cytotoxicity. Its acetyla-
tion and the presence of a hydroxyl at C-15 had a
detrimental effect.
However, in studies on triterpene glycosides
isolated from sea cucumbers Cucumaria sp. (Jin
et al. 2009) against various leukemia cells, acetyl
group at C-16 (as opposed to keto group) was
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selected as the structural feature responsible for
increased cytotoxicity of these compounds.
Acetylation at another position, namely C-25,
proved to be important for the growth inhibitory
activity of cimigenol derivatives on the Her2 over-
expressing MDA-MB-453 human breast cancer cells
(Einbond et al. 2008). The most potent saponin was
25-acetyl-7,8-didehydrocimigenol 3-O-b-D-xylopy-
ranoside with an IC50 5 lmol l
-1.
Interesting observations were made in a compar-
ison of cytotoxic activity against glioblastoma
U251MG cells of saponins isolated from Ardisia
pulsilla (Tian et al. 2009). Five tested compounds
were all monodesmosides and belonged to two
closely related aglycone types, those with olean-12-
ene or a 13,28-epoxyoleanane skeleton. The saponins
differed in a constituent at C-30 and in the length of
the branched sugar chain (tetra- or hexasaccharide).
Based on the results from this study, as well as earlier
reports on similar compounds, it was concluded that
both the aglycone and the sugar moiety play an
important role in their cytotoxicity. It seems that the
most important structural feature is the presence of
the aldehyde or methyl group at C-30, a replacement
of which by a carboxyl or a hydroxymethyl results in
loss of activity. Moreover, the results from this study
were also interesting in terms of the used cell line
because glioblastoma multiforme is very resistant to
chemotherapy. The most active saponin (3b-O-{b-D-
glucopyranosyl-(1 ? 2)-{b-D-xylopyranosyl-(1 ? 2)-
[b-D-glucopyranosyl-(1 ? 3)-b-D-glucopyranosyl-
(1 ? 3)]-b-D-glucopyranosyl-(1 ? 4)}-a-L-arabino-
pyranosyl}-16a-hydroxy-13b,28-epoxy-oleanan-30-al)
had IC50 of 2.57 lmol l
-1 and at the same time did not
affect the growth of normal human astrocytes at
concentration as high as 100 lmol l-1.
Another species of genus Ardisia, A. japonica,
afforded 21 saponins which were evaluated against
three human cell lines, HL-60 (myeloid leukemia),
KATO-III (stomach adenocarcinoma) and A549
(lung adenocarcinoma) (Chang et al. 2007). All
cytotoxic saponins (IC50 from 1.9–37.2 lmol l
-1)
were derivatives of either cyclamiretin A or proto-
primulagenin A, that is they shared a common 13,28-
epoxyoleanane skeleton and possessed a branched
sugar chain with a-L-arabinopyranose as the first
sugar attached at C-3 of the aglycon. Comparison of
IC50 values indicated that the following structural
features seem to improve the activity: (1) hydroxyl
moiety at C-16, (2) glucopyranosyl moiety at C-2 of
a-L-arabinopyranose.
Although many studies reported that while mono-
desmoside saponins are cytotoxic, bidesmosides are
often inactive in the same cell lines it was noteworthy
that a mixture of two bidesmosides from Sideroxylon
foetidissimum subsp. gaumeri exerted cytotoxic
activity (IC50 11.9 lg ml
-1) against the murine
macrophage-like cell line RAW 264.7 (Sánchez-
Medina et al. 2009). Moderate activity against human
leukemia HL-60, stomach adenocarcinoma KATO-III
and lung adenocarcinoma A549 cells, was also
reported for echinocystic acid bidesmoside, impatie-
noside G (IC50 21.8–36.7 lmol l
-1) (Li et al. 2009).
However, other compounds tested in this study,
including mono- and bidesmosides of soyasapogenol
A were inactive at concentrations 50 lmol l-1.
It seems therefore, that the cytotoxicity of bides-
mosidic saponins varies dependent of the aglycone.
The presence of an oligosaccharide ester at C-28 was
postulated to be an important structural feature essen-
tial for growth inhibitory activity of many cytotoxic
acacic acid-type saponins, such as for example avicins
from Acacia victoriae or julibrosides from Albizia
julibrissin. Other structural features essential for their
action include a monoterpene-quinovopyranosyl moi-
ety at C-21 and a hydroxyl group at C-16 (Cao et al.
2007). The crucial role in mediating cytotoxicity is
attributed to an ester substituent at C-21 (Noté et al.
2009) and for the most potent activity, two mono-
terpene-quinovopyranosyl groups acylated at C-21 of
the aglycon are required (Liu et al. 2009b).
Structurally related compounds isolated from
Albizia gummifera had significant antiproliferative
effects (IC50 0.1–6.6 lmol l
-1) on the histiocytic
lymphoma U937, human ovarian A2780, colon HT-
29, nonsmall-cell lung H522-T1, and breast MDA-
MB-435cancer cell lines (Cao et al. 2007). Also,
bidesmosidic julibrozide J21, with acacic acid agly-
cone, showed a marked inhibitory action against
human liver cancer cell line Bel-7402 (Zou et al.
2006b). From a study of Melek et al. it was concluded
that saponins containing acacic acid lactone as the
triterpene moiety are inactive (Melek et al. 2007).
Some of fairly early SAR experiments were
performed on saponins with previously reported
antitumor activity, namely tubeimosides I–III from
Bolbostemma paniculatum (Yu et al. 2001). These
compounds are oleananes belonging to a group of
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rare cyclic bidesmosides with a 3-hydroxy-3-methyl-
glutarate bridge joining two sugar chains. Tubeimo-
sides I–III differ in the aglycone part by the presence
or absence of a hydroxyl at C-16 and in the linkage
position of the bridge between two sugar chains.
Antitumor activities were compared in vivo on
transplantable mouse S180 in BALB/c mice. The
obtained data indicated that C-16 hydroxyl group is
important for the activity and at the same time for the
decrease in toxicity, whereas sugar chain linkage
such as in tubeimoside III, elevates antitumor effect
but also the toxicity of the compound. So, tube-
imoside II seemed to be the most promising agent
for cancer chemotherapy among saponins of
B. paniculatum.
Correlation between the structure and cytotoxicity
of steroid saponins
Influence of sugar chain
In 2001, Mimaki et al. reported some structure-
activity relationships of steroidal saponins. The
compounds were mainly isolated from the Liliaceae
plants and tested against HL-60 human promyelo-
cytic leukemia cells. Diosgenin b-D-glucoside was
not active (IC50 [ 20 lg ml
-1), however an addi-
tional a-L-rhamnopyranosyl moiety at C-2 of the
glucose considerably increased the activity (IC50
1.8 lg ml-1). Among different diosgenin rhamno-
pyranosyl-glucosides only a-L-rhamnopyranosyl-
(1 ? 2)-b-D-glucopyranoside of diosgenin was
active. Compounds with a-L-Rhap moiety at C-3 or
C-4 of the glucose showed no cytotoxic activity.
Further attachment of a-L-arabinofuranosyl, b-D-glu-
copyranosyl or a-L-rhamnopyranosyl groups to C-3
or C-4 of the inner glucosyl group did not influ-
ence activity or caused only slight increase
(0.5–3.3 lg ml-1). The authors concluded that the
number and the sequence of sugar moieties seem to be
important for cytotoxic activity (Mimaki et al. 2001).
Some diosgenyl a-L-rhamnopyranosyl-(1 ? 2)-
b-D-glucopyranoside analogues with different mono-
saccharides (D-Glc, D-Gal, D-Man, L-Ara, D-Xyl, and
D-Fuc) in the place of the rhamnose moiety were
synthesized (Hernández et al. 2008). Their effects on
the growth of human myeloid (HL-60 and U937) and
melanoma (SK-MEL-1) cell lines were evaluated.
Similarly to Mimaki’s studies, diosgenyl a-L-rhamno-
pyranosyl-(1 ? 2)-b-D-glucopyranoside displayed
strong cytotoxic activity with an IC50 of about
5-7 lmol l-1. Glycosides containing other sugar
instead of rhamnose were, in general, less cytotoxic
in this study. Selective acetylation of a hydroxyl group
at C-60 of glucose of diosgenyl a-L-rhamnopyranosyl-
(1 ? 2)-b-D-glucopyranoside did not change signif-
icantly the cytotoxic activity when compared to
deacetylated compound. It was concluded that free
hydroxyl group at C-60 of glucose may be of no
importance for this effect. Additional acetylation of
the hydroxyl group at C-400 of rhamnose significantly
decreased the cytotoxic activity. The reduction of
cytotoxic effect was observed when a second rham-
nose was attached to C-400 of rhamnose. A significant
decrease in growth inhibitory activity was observed
on SK-MEL-1 in response to the compounds having
other than rhamnose moiety attached to glucose
residue (IC50 [ 100 lmol l
-1). These results showed
the importance of rhamnose for diosgenyl glycosides’
cytotoxicity.
Diglycosides with mannose or fucose moieties
induced significant G1 arrest at the expense of S- and
G2/M-phase cell population. Diosgenyl a-L-rhamn-
pyranosyl-(1 ? 2)-b-D-glucopyranoside produced
alterations in cell cycle progression, induced G2-M
arrest at the expense of G1 phase cell number. No
evidence of changes in the cell cycle phases was
observed in response to compound containing a
galactosyl group (Hernández et al. 2008).
In Mimaki’s studies saponins with glycosyl groups
at C-1 of aglycone showed no activity, the only
exceptions were compounds possessing some acyl
groups at the glycosyl moiety. Also, a (25S)-spirost-5-
ene-1b,3b-diol with a sugar chain containing D-fucose
and L-rhamnose was cytotoxic. The authors suggested
that cytotoxic activity of such saponins was connected
with a certain degree of lipophilicity (Mimaki et al.
2001).
The importance of the number of sugar moieties in
a sugar chain and the structure of aglycone was also
confirmed by the studies on saponins isolated from
Agave fourcroydes. Chlorogenin, hecogenin and
tigogenin hexasaccharides (with the same sequence
of sugar chains) showed cytotoxic activity against
HeLa cells (IC50 13.1, 5.2, and 4.8 lg ml
-1, respec-
tively), while diglucosides were inactive (Ohtsuki
et al. 2004).
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The correlation between the cytotoxic activity and
the number of sugar residues in the sugar chain was
observed in cytotoxicity test of saponins isolated
from Paris polyphylla var. yunnanensis. Diosgenin
tetrasaccharide showed stronger cytotoxic activity
than compounds containing three or two sugar resi-
dues. Two diosgenin and pennogenin disaccharides
exhibited the lowest inhibtion properties. Diosgenin-
3-O-a-L-arabinofuranosyl-(1 ? 4)-[a-L-rhamnopyr-
anosyl-(1 ? 2)]-b-D-glycopyranoside showed higher
cytotoxicity rate than diosgenin-3-O-a-L-rhamnopyr-
anosyl-(1 ? 4)-[a-L-rhamnopyranosyl-(1 ? 2)]-b-D-
glyco-pyranoside (1.85 and 3.06 lmol l-1, respectively).
Although the number of monosaccharides in the
sugar moiety were the same they varied in compo-
sition (Yan et al. 2009).
Influence of aglycone
A series of steroidal sapogenins (diosgenin, tigoge-
nin, sarsasapogenin, smilagenin and others) has been
tested for the influence on cell proliferation, cell
cycle distribution and apoptosis in 1,547 human
osteosarcoma cells. To study the role of a 5,6-double
bond in the cytotoxic effect, the activities of
diosgenin (possessing a double bond), smilagenin
and tigogenin (5b and 5a stereoisomers respectively;
no 5,6-double bonds) were compared.
Diosgenin induced apoptosis in 1,547 cells (5.6-
fold compared to control) whereas smilagenin and
tigogenin showed weak apoptotic activity. Diosgenin
and smilagenin induced strong inhibition of cell
proliferation while tigogenin inhibited it only mod-
erately. After 24 h treatment diosgenin and smilage-
nin blocked cell cycle in G0/G1 phase in 54.1 and
54.9% respectively compared to 39.6% for control
while tigogenin had no effect. The results from this
study indicate that the difference in the spatial
conformation of the A- and B-rings and the presence
or lack of 5,6-double bond do not affect the mode of
action on the cell cycle (diosgenin and smilagenin
arrested the cell cycle in the same phase) (Trouillas
et al. 2005).
The importance of stereoisomery at C-25 on cell
proliferation with regard to apoptosis and cell cycle
data were studied using sarsasapogenin and smilage-
nin (the 25-isomer of smilagenin). Sarsasapogenin
showed strong apoptotic effect whereas smilagenin
induced weak apoptosis. Sarsasapogenin arrested cell
cycle in G2/M (52.6% compared to 20.3% for
control), while smilagenin blocked cell cycle in
G0/G1 phase. Sarsasapogenin significantly enhanced
DNA fragmentation (6.9-fold compared to control).
Results from this study provide evidence for the
importance of the conformation at C-25 (Trouillas
et al. 2005).
The R/S configuration at C-25 was essential for
selectivity in leukemia cells observed between methyl
protoneogracillin (C-25 S configuration) and methyl
protogracillin (C-25 R configuration) isolated from the
rhizomes of Dioscorea collettii var. hypoglauca. A
6–11 fold difference was observed on three leukemia
cell lines (CCRF-CEM, MOLT-4 and PRMT-8226),
GI50 for methyl protoneogracillin was 1.79, 4.59, and
1.57 lmol l-1, respectively whereas for methyl pro-
togracillin 20.2, 25.6, and 12.0 lmol l-1, respectively.
However, no difference in selectivity against solid
tumors was observed for these two compounds,
indicating that R or S configuration at C-25 was not
critical for the activity against solid tumors (Hu and
Yao 2003b).
In vitro studies on steroidal saponins of Paris
polyphylla var. yunnanensis displayed that glycosides
of diosgenin were more active against LA 795 cells
than those of pennogenin-type (which belongs to the
17-hydroxy-steroidal sapogenins) (Yan et al. 2009).
In the studies on cytotoxic activity of steroidal
saponins isolated from Liliaceae plants the introduc-
tion of C-17 hydroxyl group to diosgenyl glycoside
reduced the cytotoxicity slightly whereas additional
C-27 hydroxyl group considerably decreased the
cytotoxic activity (Mimaki et al. 2001).
The cytotoxic activity of steroidal saponins isolated
from the fresh whole plants of Agave utahensis against
HL-60 human promyelotic leukemia cells was studied.
Two smilagenin diglycosides and one trisaccharide
showed high cytotoxicity with IC50 4.9–7 lg ml
-1.
The additional C-2 hydroxyl group or C-12 car-
bonyl group in the 5b-spirostanol structure signifi-
cantly reduced cytotoxic activity (Yokosuka et al.
2009).
Methyl protodioscin (a furostanol compound) and
dioscin (a spirostanol glycoside) isolated from the
root of Polygonatum zanlanscianense were tested
against human leukemia HL-60 cells in vitro. The
spirostanol glycoside induced differentiation, apop-
tosis and cytotoxicity in the HL-60 cells, while the
other had no effect. It was concluded that the
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spirostanol structure must be critical in the effects on
the HL-60 cells (Wang et al. 2001).
Some spirostanol diosgenin derivatives were inves-
tigated for cytotoxic effect against human colorectal
HCT 116 carcinoma cells. Compounds which bear S
and Se atoms on the diosgenin F ring were synthesized.
Oppenauer oxidation of diosgenin, solasodin (a nitro-
gen analogue of diosgenin) and the synthesized
heterospirostanols gave corresponding a,b-unsatu-
rated ketones. Amongst compounds studied solasodine
and its a,b-unsaturated ketone derivative exhibited
high activity (IC50 = 6 and 14 lmol l
-1, respec-
tively). The activities of other compounds were lower.
The results of this study suggested that N-atom on the F
ring was important for cytotoxic activity against HCT
116 cells. The activity of N-spirostanol compound was
higher when there was no conjugated system in the A
ring (Quan et al. 2002).
Cytotoxic mechanisms of saponins
Saponins are potential anticancer agents, with differ-
ent mechanisms of action. Their cytotoxic effects
may be due to either apoptosis inducement or non-
apoptotic cell death stimulation. There is a number of
well-known processes which lead to the same
effect—cell death—but involve different mechanisms
of action, like stimulation of autophagic cell death,
decrease in NO production in cells, or cytoskeleton
integrity disassembly.
The cytotoxic effects of saponins, discussed in this
paper, were studied mainly in vitro, but also some in
vivo experiments were conducted. The most impor-
tant mechanisms are summarized in Table 4.
In vitro experiments
Apoptosis—programmed cell death—is one of the
most important processes involved in the regulation
of tissue development and homeostasis. It is also well
known that research of novel anticancer agents in
recent years focuses on their potential pro-apoptotic
properties. The process may be initiated either at
plasma membrane (extrinsic pathway) or within the
cell (intrinsic pathway) (Bachran et al. 2008).
The extrinsic pathway is triggered by the activa-
tion of specific pro-apoptotic receptors on the cell
surface, which are stimulated by specific molecules
known as pro-apoptotic ligands (Apo2L/TRAIL and
CD95L/FasL). Among the reviewed saponins, only
saponin fraction isolated from Bupleurum kaoi
induced the extrinsic pathway of apoptosis (Hsu
et al. 2004).
The influence of triterpene saponin-enriched frac-
tion (SEF) from Bupleurum kaoi on human non-small
cell lung cancer A549 was investigated by Hsu
et al. The antiproliferative effect of SEF was
observed, in a dose-dependent manner, with IC50
values 196 lg ml-1. Inhibition of proliferation of the
cells was through the apoptotic pathway, with the
observed enhancement in Fas and its two ligand
forms, membrane-bound Fas ligand and soluble Fas
ligand. In cells treated with caspase-8 inhibitor,
growth inhibition and apoptosis were significantly
decreased, which also proves an important role of
Fas/FasL system in SEF-mediated apoptosis of A549
cells (Hsu et al. 2004).
The intrinsic pathway of apoptosis begins usually
in response to different types of cell stress: cellular
signals resulting from DNA damage, a defective cell
cycle, detachment from the extracellular matrix,
hypoxia, loss of cell survival factors. This pathway
involves the release of pro-apoptotic proteins that
activate caspase enzymes from the mitochondria, but
also depends on the balance between the pro- and
anti-apoptotic proteins from Bcl-2 superfamily (Xu
et al. 2009).
The immunosuppressive activity of a triterpene
saikosaponin a from Bupleurum falcatum on the
concanavalin A (Con A) stimulated mouse CD3? T
cells, isolated from the lymph node of BALB/c mice,
was examined, as well as the underlying mechanism
of the action. The compound had potent antiprolif-
erative effect, and also significantly inhibited the
activation of the cells, in a concentration-dependent
manner. Moreover, saikosaponin a potently sup-
pressed the production of IL-2, IFN-c and TNF-a in
T cells stimulated by Con A. The G0/G1 arrest of the
activated T cells by saikosaponin a was also
observed, and the effect was due to down-regulating
of CDK6 and cyclin D3 protein level and up-
regulating of p27kip protein level. The apoptosis of
the activated T cells, in comparison to the non-
activated cells, was induced by the compound in
dose-dependent manner, probably via mitochondrial
pathway—a significant collapse of the mitochondrial
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Table 4 Mechanisms of cytotoxic activity of saponins
Process Mode of action References
Apoptosis
intrinsic
pathway
Cytochrome c release Sun et al. (2009a), Li et al. (2008), Xu et al. (2009), Wang et al. (2008), Jin
et al. (2009), Zhang et al. (2008), Haridas et al. (2009), Hernández et al.
(2004), Siu et al. (2008), Liu et al. (2005)
Mitochondria membrane
depolimerization
GADD153/CHOP transcription
factor expression increase
Caspase 3 and 9 activation
PARP-1 cleavage
MAPK cascade activation
p-STAT-3 decrease
Bcl-2, c-myc, survivin
downregulation
VEGF downregulation
p53 stimulation
NF-jB inhibition
JAKs dephosphorylation
Protein phosphatase-1 activation
Intracellular Ca2? homeostasis
disruption
Apoptosis
extrinsic
pathway
Fas enhancement Hsu et al. (2004)
Fas ligand enhancement
Apoptosis non-
specified
Telomerase activity inhibition Kim et al. (2008a)
Cell cycle arrest CDK6 downregulation Sun et al. (2009a, b), Ellington et al. (2005), Raju and Mehta (2009),
Srinivasan et al. (2009), Liu et al. (2005)
Cyclin D3 downregulation
Cyclin D1 downregulation
p27kip upregulation
CDK2 inhibition
Autophagy Microtubule-associated protein
light chain-3 increase
Ellington et al. (2005), Xu et al. (2007a)
Autophagic vacuoles number
increase
AMPK-TSC2 regulation
Cellular ATP decrease
AMPK activation
Angiogenesis
inhibition
Thrombospondin-1 expression
increase
Wang et al. (2008), Tian et al. (2005)
PKC expression decrease
ERK activation
P38MAPK activation
Endothelial cell proliferation
inhibition
Tube-formation inhibition
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membrane potential and release of cytochrome c
from mitochondria to cytosol was observed (Sun
et al. 2009a).
The anticancer properties of ardisiacrispin (A ? B),
a mixture (fixed proportion 2:1) of triterpene saponins
ardisiacrispin A and B from Ardisia crenata, against a
number of human cancer cell lines were evaluated. The
highest antiproliferative effect of the tested substance
was observed on human hepatoma Bel-7402 cells.
Moreover, the substance induced apoptosis in
Bel-7402 cells, which was observed by the changes
of the mitochondrial membrane depolarization, mem-
brane permeability enhancement and nuclear conden-
sation, and the effects were dose-dependent (Li et al.
2008).
Cytotoxic effect of a triterpene saponin tubeimo-
side 1 (TBMS1) from Bolbostemma paniculatum was
tested on HeLa cells. In the cells treated with the
compound, profound protein alterations were
observed, suggesting apoptotic process, with the
involvement of mitochondria and endoplasmic retic-
ulum. TBMS1 induced the depletion of mitochondrial
transmembrane potential, causing the activation of
caspase-dependent apoptotic cell death. Moreover,
the increased expression of GADD153/CHOP tran-
scription factor, associated with growth arrest and
apoptosis in the event of prolonged ER stress, was
detected. The results of the study suggest the
cytotoxic effect of TBMS1 through the mitochon-
drial, but also ER stress cell death pathways (Xu et al.
2009).
The effect of b-escin sodium on proliferation,
migration and apoptosis of human umbilical vein
endothelial cells HUVEC and ECV304 was studied.
The compound inhibited both endothelial cell lines
proliferation in dose-dependent manner, also causing
apoptosis of the cells. Moreover, b-escin sodium
suppressed endothelial cells migration and motility.
The possible mechanism of action of the compound
may be through increasing expression of thrombo-
spondin-1 and decreasing expression of protein kinase
C, an intracellular messenger necessary for endothelial
cells proliferation and migration. Additionally, the
compound activates p44/42 mitogen-activated protein
kinase (ERK) and p38 mitogen-activated protein
kinase (p38MAPK), which are involved in MAPK
signaling cascade, whose activation is linked to cell
proliferation, motility and apoptosis. The obtained data
indicate the potential anti-angiogenic activity of
b-escin sodium due to its direct effects on endothelial
cells (Wang et al. 2008).
The effects of two triterpene glycosides: frondo-
side A and cucumaroside A2-2, isolated from sea
cucumber Cucumaria frondosa, on human leukemia
cells death-inducing capability were determined and
compared in this study. Both compounds strongly
induced apoptosis of leukemic cells, but the process
was more rapid and potent in cells treated with
frondoside A, in comparison to cucumaroside A2-2.
The obtained data indicate that only apoptosis
induced by cucumaroside A2-2 was caspase-depen-
dent (Jin et al. 2009).
The influence of avicin D and G, triterpene
saponins obtained from seedpods of Acacia victoriae,
on metabolic state of isolated rat mitochondria was
studied by Lemeshko et al. Following avicin
Table 4 continued
Process Mode of action References
Cytoskeleton
disintegration
Microtubule dissasembly Li et al. (2008), Ma et al. (2008), Einbond et al. (2008), Galanty et al. (2008),
Gnoula et al. (2008)
Tubulin polymerization inhibition
Actin filaments disruption
Intracellular ATP decrease
Nucleus morphology changes
Metastasis
inhibition
Cell motility and migration
inhibition
Tian et al. (2005), Galanty et al. (2008), Man et al. (2009)
Cell adhesion inhibition
MMP-2, MMP-9 downregulation
TIMP-2 upregulation
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treatment, a significant decrease in oxygen consump-
tion rate was observed. This process was reversible
by the addition of exogenous cytochrome c, which
suggests that avicin-induced inhibition of respiration
may be due to the release of cytochrome c from
mitochondria. Moreover, avicins increased the rote-
none-intensive oxidation of external NADH in the
presence of exogenous cytochrome c, which may
indicate that the compounds increase permeabiliza-
tion of mitochondrial membrane to cytochrome c.
The results explain selective induction of apoptosis in
tumor cells by avicins, especially avicin G (Leme-
shko et al. 2006).
The influence of avicin D, also isolated from
A. victoriae, on different cutaneous T-cell lympho-
mas cell lines (CTCL): MJ, Hut78, HH and also on
cells obtained from patients with Sézary syndrome
and healthy donors, with normal CD4? and activated
CD4? T-cells was investigated by Zhang et al.
Avicin D induced apoptosis in three CTCL cell lines,
in time- and dose-dependent manner. Apoptotic cell
death was more notable in avicin D-treated cells from
the patients with Sézary syndrome than in cells from
healthy donors. The compound activated caspase-3 in
CTCL cell lines and cells from Sézary syndrome
patients, but not in cells from healthy donors. Avicin
D did not influence the expression of signal trans-
ducer and activator of transcription-3 (STAT-3) but it
decreased phosphor-signal transducer and activator of
transcription-3 (p-STAT-3) protein level in CTCL
cell lines and cells from the Sézary syndrome
patients. The compound also selectively inhibited
the expression of antiapoptotic protein bcl-2, while
did not influence the expression of proapoptotic
protein bax in CTCL cells and cells from the patients
with Sézary syndrome. In conclusion, avicin D
selectively induced apoptosis, which was probably
dependent on caspase-3 and downregulation of
p-STAT-3 and bcl-2 proteins (Zhang et al. 2008).
Haridas et al. investigated the effect of avicin D on
phosphorylation/dephosphorylation of Stat-3 process
in a number of human tumor cell lines: U266, RPMI-
8226, SKO-007, MM1, A431, OVCAR3, HepG2.
Avicin D stimulated dephosphorylation of Stat-3 in
all cell lines, what lead to a decrease in transcription
rate of Stat-3. This process may be due to avicin D
influence on dephosphorylation of JAKs (Janus
kinases) and activation of protein phosphatase-1.
Moreover, in avicin D-treated cells the reduction of
expression of Stat-3-regulated proteins—c-myc,
cyclin D1, Bcl2, survivin, VEGF—was observed.
Downregulation of Stat-3 activity and inhibitory
effect on expression of pro-survival proteins contrib-
uted to the induction of apoptotic process in tumor
cells treated with avicin D. The results of the study
suggest that avicin D, by the inhibition of Stat-3
activity, suppressed also proinflammatory and pro-
oxidant stromal environment of tumors. Moreover,
avicin D activated PP-1, a cellular economizer, which
can lead to redirecting metabolism of tumor cells
from growth promoting to energy sparing pathways
(Haridas et al. 2009).
Steroid sapogenin icogenin, isolated from Dra-
caena draco, was active against the myeloid leuke-
mia cell line HL-60 (IC50 2.6 lmol l
-1 at 72 h) and
inhibited cell growth by induction of apoptosis.
Nuclear changes and the fragmentation of poly
(ADP-ribose) polymerase-1, an enzyme involved in
DNA repairing and in apoptosis process, were
observed (Hernández et al. 2004).
Polyphyllin D (PD), a steroid saponin (Fig. 1)
isolated from Paris polyphylla, was identified as a
potential ER stress inducer on human non-small cell
lung cancer NCI-H460 cell line. PD treatment led to
upregulation of typical ER stress-related proteins/
genes including glucose-regulated protein 78 (BiP/
GRP78) and protein disulfide isomerase (PDI). In
particular, elevated expression of C/EBP homologous
transcription factor (chop) and activation of caspase-4
occurred at early time point (8 h) of PD treatment,
suggesting an initial ER stress-mediated apoptosis.
Induction of tumor suppressor p53, disruption of
mitochondrial membrane, activation of caspase-9 and
caspase-3 were also detected upon prolonged PD
treatment. Collectively, these data revealed that PD
induced the cytotoxic effect through a mechanism
initiated by ER stress followed by mitochondrial
apoptotic pathway (Siu et al. 2008).
Diosgenin, a naturally occurring steroidal sapoge-
nin, has been suggested to play an important role in
anticancer protection. Cytotoxic activity of the com-
pound is mainly due to its inhibition of cell cycle
signaling and induction of apoptosis. It induced G1
phase cell cycle arrest in 1,547 osteosarcoma cells
and induced apoptotic demise. The activation of p53
and binding of NFjB to DNA independent of PPAR-
c was demonstrated (Raju and Mehta 2009). In other
experiment, diosgenin induced cell cycle G2/M arrest
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and apoptosis. The disruption of intracellular Ca2?
homeostasis, generation of reactive oxygen species
and caspase activation were observed (Liu et al.
2005).
Srinivasan et al. examined the effect of diosgenin
on Akt signaling in estrogen receptor positive and
negative breast cancer cells. Diosgenin inhibited
pAkt expression and Akt kinase activity, but it did
not affect the levels of PI3K, which lead to the
inhibition of Akt downstream targets, NF-jB, Bcl-2,
survivin and XIAP and the Raf/MEK/ERK pathway
in ER?, but not in ER- BCa cells. In both ER? and
ER- BCa cells diosgenin caused G1 cell cycle arrest
by downregulating cyclin D1, cdk-2 and cdk-4
expression what resulted in cell proliferation inhibi-
tion and induced apoptosis. Diosgenin was not
significantly toxic towards the normal breast epithe-
lial cells MCF-10A (Srinivasan et al. 2009).
Platycodin D, a triterpenoid bidesmoside isolated
from the root of Platycodon grandiflorum, was
examined as a potential antitumor compound on
different human leukemia cell lines: U937, THP-1
and K562. The compound exerted a dose-dependent
cytotoxic effect, and also inhibited the activity of
telomerase via down-regulation of hTERT (telome-
rase reverse transcriptase) expression, which can be
associated with non-specified apoptotic process. In
platycodin D treated cells the decrease of c-Myc and
Sp1 (regulators of hTERT transcription) protein
levels and reducement in their DNA binding activity
were observed. The compound also down-regulated
the activation of Akt, and thus reduced phosphory-
lation and nuclear translocation of hTERT. The
results indicate that cytotoxic effect of platycodin D
on human leukemia cells may be due to telomerase
activity suppression through transcriptional and post-
translational suppression of hTERT (Kim et al.
2008b).
Anti-angiogenic and antitumor properties of PE
(Fig. 1), a sulfated triterpene saponin isolated from
the sea cucumber Pentacta quadrangularis, were
examined. The compound inhibited proliferation,
migration, adhesion and tube-formation in two types
of human endothelial cells: HMECs and HUVECs.
Moreover, non-specified apoptosis in the cells treated
with PE was also observed (Tian et al. 2005).
Autophagy is a process used by stressed cells to
catabolize their own contents (proteins, organelles) to
provide cellular energy. The process may also inhibit
tumor growth and malignant transformation of cells,
which is an interesting alternative, especially in
apoptosis-resistant cancer cells (Xu et al. 2007a).
Ellington et al. evaluated the effect of a purified
soybean B-group saponin extract on human HCT-15
colon adenocarcinoma cells. The extract significantly
decreased the viability of the cells, in dose- and time-
dependent manner and the cells were accumulated in
phase S of the cell cycle, due to the reduction of
cyclin-dependent kinase (CDK2) activity. The exam-
ination of the cells treated with the extract under the
transmission electronic microscope indicated the non-
apoptotic programmed cell death morphology
changes—a number of autophagic vacuoles, suggest-
ing autophagic cell death. Moreover, the increased
level of microtubule-associated protein light-chain 3,
a specific marker of macroautophagy, following
soyasaponin treatment was observed (Ellington
et al. 2005).
The effect of avicin D and avicin G, isolated from
the root of Acacia victoriae, on the autophagy
induction in a number of human tumor cells: A549,
SKOV3, PC3, U2OS, MDA-MB-231 and T47D was
examined. Cells treated with an apoptosis inhibitor
(benzyloxycarbonylvalyl-alanyl-aspartic acid (O-
methyl)-fluoro-methylketone) still could undergo cell
death under the influence of avicin D, what indicated
non-apoptotic cell death. Moreover, this process was
not due to the deregulation of amino acids but based
on the obtained data it seems that avicin D induced
disruption of cellular bioenergetics, what in turn
suggested autophagy. Avicin D decreased cellular
ATP levels and stimulated the activation of AMP-
activated protein kinase (AMPK), which suggests the
possible mechanism of avicin D-induced autophagic,
caspase-independent cell death, via regulation of
AMPK-TSC2 (tuberous sclerosis complex 2)-mTOR
(mammalian target of rapamycin) pathway (Xu et al.
2007).
The excessive production of nitric oxide (NO) in
the cell may be due to viral or bacterial infections and
can promote pathogenesis by promoting oxidative
stress, tissue injury and even cancer. There is some
evidence that NO production inhibitory activity of
saponins is correlated with their cytotoxic effect
(Tundis et al. 2009).
The cytotoxic activity of four triterpene sapo-
nins—saikosaponin a, buddlejasaponin IV, song-
arosaponin D and saikosapogenin a (obtained by
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hydrolysis of sugar unit from saikosaponin a)—from
the roots of Physospermum verticillatum, against seven
cancer cell lines—ACHN, C32, Caco-2, COR-L23,
A375, A549 and Huh-7D12—and skin fibroblasts
142BR was examined. All the saponins exhibited
strong cytotoxic activity against COR-L23 line,
whereas none of the tested compounds was active
against the fibroblasts. Buddlejasaponin IV and song-
arosaponin D inhibited NO production in lipopolysac-
charide-stimulated murine monocytic RAW 264.7
macrophages (Tundis et al. 2009).
Normal cell division, cellular motility, intracellu-
lar transport and proper cell shape are all dependent
on cytoskeleton integrity and stability. Saponins may
stimulate disintegration of microtubular network or
actin filaments of cancer cells, which can lead to
further processes of apoptotic or non-apoptotic cell
death (Ma et al. 2008; Einbond et al. 2008).
Anti-microtubule role of tubeimoside I (TBMS1),
isolated from Bolbostemma paniculatum, on human
nasopharyngeal carcinoma CNE-2Z cell line was
investigated by Ma et al. The dose- and time-
dependent inhibition of cell growth treated with
TBMS1 was significant. In the cells treated with
25 lmol l-1 of TBMS1 for 3 h the disruption of
microtubular network was observed, and the analysis
showed the increase of the cytosolic tubulin level in
the treated cells, which suggest the inhibition of
tubulin polymerization. The effect was weak in
comparison to colchicine. Moreover, the tested
compound inhibited colchicine binding to tubuline,
in contrast to vinblastine binding, which indicates the
competitive binding of TBMS1 to tubulin at colchi-
cine binding site (Ma et al. 2008).
The growth inhibitory effect of extracts and isolated
compounds from Cimicifuga species were investigated
on two human breast cancer cells: MDA-MB-453 (ER
negative, Her2 overexpressing) and MCF7 (ER
positive, Her2 low). The results indicated that the
growth inhibitory activity of these extracts was related
to triterpene glycoside composition. Actein, a purified
isolated compound, influenced the composition of
actin cytoskeleton by alteration of distribution of actin
filaments in both type of cells—actin was dispersed in
the cytoplasm and aggregated around the nucleus.
Moreover, the nuclei changed their shape in a manner
typical of apoptosis (Einbond et al. 2008).
Ardisiacrispin A and B from Ardisia crenata,
mentioned above due to their apoptotic activity, also
influenced the cytoskeleton of Bel-7402 cells, caus-
ing microtubules dissasembly (Li et al. 2008).
In our own investigations, the effect of LTS-4, a
triterpene saponoside from Lysimachia thyrsiflora,
upon the viability, proliferation, morphology and cell
motility of human melanoma HTB-140 cells and
human skin fibroblasts (HSFs) was tested. The
compound decreased the viability and cell growth
of both cell types in time- and dose-dependent
manner, and was cytotoxic against cancer cells at
significantly lower concentrations in comparison to
fibroblasts. LTS-4 affected also the morphology of
examined cells, causing vacuolization and cell shape
changes. The compound caused actin cytoskeleton
disintegration—disappearance of stress fibres and
random distribution of actin in the cytoplasm.
Moreover, LTS-4 exerted an inhibitory effect on
tumour cells motility (Galanty et al. 2008).
The mixture of steroid glycosides balanitin-6 and
balanitin-7 (referred to as bal6/7), isolated from the
kernels of African plant Balanites aegyptiaca, dis-
played high cytotoxic activity against human cancer
lines: A549 non-small cell lung cancer and U373
glioblastoma. Its activity was higher than etoposide
and oxaliplatine, but markedly lower than paclitaxel.
It was suggested that its antitumor activity resulted
from the decrease of intracellular ATP, mediated by
bal6/7, which induced in turn major disorganization
of actin cytoskeleton. The experiment indicated that
the cytotoxic effect was not mediated by apoptotic
mechanism (Gnoula et al. 2008).
In vivo experiments
Steroidal saponins of Paris polyphylla var. yunnan-
ensis (e.g. polyphyllin D, dioscin, formosanin C,
methylprotogracillin, and trillin) have been found to
possess strong antitumor activity. The experiment
was performed on T739 bearing LA795 mice which
received the saponin extract by intragastric adminis-
tration. The observed antitumor and antimetastatic
effects were due to inducing apoptosis and upregu-
lating the expression of TIMP-2 and down-regulating
the level of MMP-2 and MMP-9 (Man et al. 2009).
Oral administration of diosgenin-3-O-a-L-arabino-
furanosyl-(1 ? 4)-[a-L-rhamnopyranosyl-(1 ? 2)]-
b-D-glucopyranoside, isolated from the rhizome of
Paris polyphylla var. yunnanensis, to T739 mice
bearing LA795 lung adenocarcinoma significantly
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inhibited tumor growth (by 29.44%). The increase of
apoptosis rate in tumor cells in comparison to cells in
control mice was observed (Yan et al. 2009).
Diosgenin significantly inhibited tumor growth in
vivo in MCF-7 and MDA-231 (breast cancer) xeno-
grafts in nude mice. Both in vivo and in vitro results
(diosgenin inhibited pAkt expression and Akt kinase
activity in vitro) led authors to conclude that dios-
genin may be a potential chemotherapeutic agent for
the treatment of breast cancer, however no data on
the route of administration were given (Srinivasan
et al. 2009).
Diosgenin when administrated with diet to
azoxymethane-induced colon carcinogenesis rats
suppressed both invasive and non-invasive colon
tumor incidence (up to 60%). Experimental diet
containing 0.1% of diosgenin significantly reduced
colon tumor multiplicity (adenocarcinomas/rat) in
rats. A significant increase in BrdU labeling and
decrease in PCNA labeling in colonic crypts and
tumors was detected (Malisetty et al. 2005).
The mixture of steroidal saponins balanitin-6 and
balanitin-7 (bal6/7) isolated from Balanites aegypti-
aca led to increase of the survival time of mice
bearing murine L1210 leukemia grafts to the same
extent as vincristine, when administered i.p. (Gnoula
et al. 2008).
Fifteen triterpene saponins from Pulsatilla kore-
ana were administered intraperitoneally to BDF1
mice bearing Lewis lung carcinoma. Saponins con-
taining an ester group at C-28 of the aglycone were
inactive while those with a-L-rhamnopyranosyl-
(1 ? 2)-a-L-arabinopyranosyl moiety at C-3 and a
free carboxylic acid at C-28 of the oleanane skeleton
had the highest antitumor potency. The authors
claimed that the oleanane-type saponins were more
active in vivo than the lupane-type saponins. The
most potent antitumor compound was hederagenin
3-O-a-L-rhamnopyranosyl-(1 ? 2)-[b-D-glucopyr-
anosyl-(1 ? 4)]-a-L-arabinopyranoside, the activity
of which was higher than standard chemotherapeutic
agent—paclitaxel (Bang et al. 2005).
In the study by Wang et al, hederagenin saponin
macranthoside B, isolated from the flower buds of
Lonicera macranthoides, was injected intravenously
to BALB/cA nude mice. The compound significantly
supressed the tumor growth and the effect was similar
to cyclophosphamide treated control group (Wang
et al. 2009).
PE, a triterpene saponin isolated from the sea
cucumber Pentacta quadrangularis, suppressed spon-
taneous angiogenesis in chorioallantoic membrane of
the chicken embryo at very low concentrations
(5 nmol l-1 per egg). Moreover, in two animal tumor
models: sarcoma 180 and hepatoma 22, PE on
intravenous administration significantly inhibited
tumor growth by triggering apoptosis. It was also
shown that PE suppressed the active forms of
VEGFR2 (vascular endothelial growth factor), Akt,
ERK (extracellular signal-regulated kinase), FAK
(focal adhesion kinase) and paxillin, which mediate
the angiogenesis of endothelial cells and apoptosis
(Tian et al. 2005).
Avicin D from Acacia victoriae inhibited the level
of VEGF (vascular endothelial growth factor) and
CD31, an endothelial cell marker indicating the
microvascular networks within the cells, in mouse
skin carcinogenesis model. The compound was
applied to the shaved skin of animals. The results
suggest its antiangiogenic potential (Haridas et al.
2009).
Saponins-toxin cytotoxicity enhancement
The combined application of saponins with other
antitumor compounds may increase cytotoxic activity
of the latter, which is an interesting new possibility in
cancer treatment research. One of the first experi-
ments was done by Hebestreit (Hebestreit and Melzig
2003) on the saponins from Agrostemma githago
seeds. The agrostemmasaponins significantly
increased cytotoxicity of agrostin, a toxic protein of
the seeds. The effect was probably due to the
enhanced penetration of agrostin, when applicated
with the saponins, through the cell membrane.
Although no summarizing review has been published
so far, a number of experiments were conducted in
recent years to examine this promising option in
tumor therapy.
In vitro experiments
Bachran et al. analyzed the influence of seven
saponins: saponinum album (from Gypsophila pan-
iculata L.), b-aescin (from Aesculus hippocastanum
L.), quillajasaponin (from Quillaja saponaria Mol.),
hederasaponin C (from Hedera helix L.), ginsenoside
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Rd (from Panax ginseng C.A. Mey.), glycyrrhizic acid
(from Glycyrrhiza glabra L.) and helianthoside 2
(from Helianthus annuus L.), on the cytotoxicity
enhancement of a targeted chimeric toxin, composed
of saporin and human epidermal growth factor, against
untransfected Swiss mouse embryo NIH-3T3 cells and
HER14 cells (NIH-3T3 cells transfected with human
epidermal growth factor receptor). The compounds
differed in their structures mainly by a formyl group at
C-4 or a branched sugar chain at C-3. Cytotoxicity of
the saponins alone was also determined against
HER14 and NIH-3T3 cells, resulting in 90% cell
survival at the concentration of 1.5 lg ml-1. This
concentration was chosen for further experiments with
saponin-toxin combination. Two of the tested sapo-
nins—quillajasaponin and saponinum album—
enhanced the cytotoxicity of the chimeric toxin by
more than 1,000-fold, the enhancement factors of the
other saponins were about tenfold only. For saponi-
num album, the effect was receptor specific, in
contrast to quillajasaponin and the saponins with low
enhancement factor. The compound decreased IC50
value from 2.4 nmol l-1 to 0.18 pmol l-1. The
authors conclude that the overall structure of the
triterpenoid aglycone cannot be solely responsible for
the enhancement, also the branched sugar chain at C-3
may play a role (Bachran et al. 2006). This statement
conforms to observations of Melzig et al. (2005), who
studied agrostin cytotoxicity enhancement by a num-
ber of different saponins. As far as aglycone structure
is concerned, the authors emphasize the importance of
formyl group at C-4 (Bachran et al. 2006). This feature
was also pointed our by Sołtysik et al. (1995), who
suggested that it may be of importance in the adjuvant
function of saponins. However, these conclusions
need further verification and more SAR studies are
certainly needed.
In 2009, the same authors described the effect of
the combined application of saponinum album and
epidermal growth factor receptor (EGFR)-targeted
chimeric toxins (SA2E) against murine mammary
adenocarcinoma cells (TSA), transfected with EGFR.
The 20,000-fold enhancement of cytotoxicity of
SA2E was observed with low concentrations of
saponinum album, in a synergistic manner (Bachran
et al. 2009).
Cytotoxicity of 3H-labeled saponinum album alone
and in combination with chimeric toxin was analysed
on HER 14 cells. 3H-labeled saponin was much less
active in comparison to their previous experiments
with unlabeled compound, which was also observed
in the case of combined 3H-labeled saponinum album
and chimeric toxin (Bachran et al. 2010).
Enhancement of cytotoxicity of lectins and pep-
tidic toxins—agrostin, microcystin-LR, nigrin b,
saporin, his-saporin, diphtheria toxin, diphtheria toxin
A-chain and ricin A-chain—against ECV-304 cells
was tested in the presence of saponinum album by
Hebestreit et al. The significant effect was observed
for lectins, but not for other peptidic toxins, with the
highest enhancement for agrostin and saporin, which
suggest the specific interaction between the lectins
and saponins. The increase in cytotoxicity of lectins
was due to the enhancement of their penetration
through the cell membrane. The effect was attenuated
by latruculin (inhibitor of endocytosis) and bafilo-
mycin (inhibitor of transport from early to late
endosomes and lysosomes) but was neither influ-
enced by brefeldin A, which causes dissolution of the
Golgi stacks nor by the addition of monosaccharides,
which support the probable mechanism of the
enhancement as receptor-mediated endocytosis. The
effect might be associated with an enhanced capacity
to form vesicles, induced by saponins, which trans-
port the proteins via endocytosis into the cell
(Hebestreit et al. 2006).
Heisler et al. investigated the effect of the
combined application of saponinum album and
chimeric toxin (consisting of saporin-3, epidermal
growth factor and a molecular adapter) on the
untransfected Swiss mouse embryo NIH-3T3 cells,
as control, HER 14 cells (NIH-3T3 cells transfected
with human epidermal growth factor receptor) and
human breast adenocarcinoma cell line MCF-7 as
targeted cell lines. Pre-applied saponin enhanced the
cytotoxic effect of the chimeric toxin against the
targeted cell lines, whereas no effect was observed on
the control cells at the same concentration. The
application of the chimeric toxin or the saponin alone
at the optimal concentration did not exhibit cytotoxic
effect, which indicates the synergistic effect of the
combined application of both compounds (Heisler
et al. 2005).
In vivo experiments
In the study by Heisler et al. saponinum album and
chimeric toxin were applied subcutaneously to
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BALB/c mice in combination or alone. Only the
combined treatment gave good therapeutic effects,
with only slight side effects. The probable mecha-
nism suggests the saponin-mediated elongation of the
retention period of endocytosed proteins inside
the endosome and thus, a greater chance of crossing
the endosomal membrane by the toxins (Heisler et al.
2005).
Bachran et al. investigated the effects of applica-
tion of saponinum album to mice bearing tumor cells.
In their first study, saponinum album and SA2E were
applicated subcutaneously to BALB/c mice with solid
tumor (TSA cells transfected with EGFR). The
application resulted in 94% tumor volume reduction,
and the effect was obtained with 50-fold lower
chimeric toxin concentration in comparison to pure
SA2E treatment. Only moderate and reversible side
effects were observed during the application (Bach-
ran et al. 2009).
In another experiment of this group, the distribu-
tion of labeled saponinum album in BALB/c mice
with tumor was measured by radioactivity analysis in
samples of organs, blood, urine and tumor tissues. No
preferential accumulation in tumor tissues or other
organs was observed and the highest radioactivity
level in the urine was after 30 min. Different
pretreatment times were measured in tumor-bearing
mice, using sequential combination of saponin (given
first) and chimeric toxin. Promising antitumor effi-
cacy was observed after 60 min pretreatment with
saponin, but no significant changes after 10 min
pretreatment with the compound. No information was
provided on the metabolism of this labeled saponin
mixture and no control group which would receive
non-labeled, acetylated saponinum album was used
for comparison of the results (Bachran et al. 2010). In
another experiment of the same group, the authors
claimed that the 3H-acetyl labeling of the sugar chain
did not influence the activity of the saponinum album
in vitro (Weng et al. 2009). However, data on saponin
labeling and its effect on the activity are still very
scarce.
Summary and conclusions
In recent years more and more researchers who
isolated new saponins from natural sources, along
with structure elucidation process, reported also on
their cytotoxic activity. This review has summarized
saponins with such an activity, which were reported
in the last 5 years and their most common mecha-
nisms of action. Correlations between structure and
the cytotoxicity of both triterpenoid and steroid
saponins were also described.
In the majority of cases these were in vitro studies,
only a limited number was performed in animal
models. The most preferred assays used were forma-
zan based (MTT) and sulphorhodamine B (SRB). The
choice of cell lines (usually from one to five) in most
reports cited in this review seemed to be random and
very few compared cells from the same tumor but
differing, e.g. in malignancy, or activity against
normal cells. Reference compounds were used in
most of studies cited here and in general saponins,
both triterpenoid and steroid, were less active.
Comparison of cytotoxicity level is however only
an approximation as there were notable differences in
IC50 values between control compounds themselves.
As far as structure-activity relationship is con-
cerned, some information was usually given by
authors who isolated, from a plant source, a greater
variety of structures. In recent years some wider
comparative studies have appeared, which directly
concentrated on establishment of SARs relevant to
cytotoxicity. From these data some general conclu-
sions can be drawn, however with such an enormous
structural diversity of saponins and still fairly limited
sets of compounds that were evaluated in this regard,
this is very difficult and may be subject to bias.
Nevertheless, it seems that for all saponins both
aglycone and sugar part play an important role for
cytotoxic activity. The main structural features
responsible for enhancement of cytotoxicity of ole-
ananes are: free carboxyl at C-28, free hydroxyl at
C-16 and acylation at C-21 and C-22. As far as sugar
moiety is concerned the presence of a-L-Arap as the
first sugar attached at C-3 in oleananes (and espe-
cially an a-L-Rhap-(1 ? 2)-a-L-Arap sequence) and
a-L-Rhap in lupanes was pointed out.
With respect to steroidal saponins, similarly to
triterpenes, the number and the sequence of sugar
residues in a carbohydrate chain, and the position of
sugar attachment to the aglycone were important for
cytotoxicity. For diosgenyl saponins the presence of
an a-L-Rhap-(1 ? 2)-b-D-Glcp sequence at C-3 was
considered beneficial for this activity. Also, elonga-
tion of the sugar chain resulted in an increase in
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cytotoxicity. However, in order to obtain a better
insight into SAR relevant to cytotoxicity there is still
a need for a greater number of studies which would
compare a wider array of compounds, ideally deriv-
atives of a single sapogenin with systematic varia-
tions of the sugar chains(s) or a group of different
sapogenins bearing identical sugar chain(s). Another
aspect worth studying in more detail are the differ-
ences between in vitro and in vivo effects, which
were highlighted by some of the reports cited in this
review. So, more studies on the bioavailability and
pharmacokinetics of saponins would certainly be
welcome.
With respect to cytotoxic mechanisms of both
triterpene and steroid saponins a wide variety of these
was reported. Cytotoxic effect of most of the
reviewed saponins was due to their ability to
stimulate apoptotic process in tumor cells, usually
through its intrinsic pathway. Moreover, non apopto-
tic processes were also involved in saponin cytotoxic
activity, such as cell cycle arrestment, autophagic cell
death stimulation, inhibiting of metastasis and cyto-
skeleton disintegration. Another interesting mode of
action that could be more exploited in the future is the
ability of some saponins, e.g. b-escin sodium and PE,
to inhibit tumor cells angiogenesis.
Yet another promising potential of saponins is their
combined application with recombinant protein toxins
that may be of use in more efficient cancer targeting.
All the cited papers described a significant enhance-
ment of cytotoxicity of chimeric toxins when applied
with saponinum album, both in vitro and in vivo.
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Chwalek M, Plé K, Voutquenne-Nazabadioko L (2004) Syn-
thesis and hemolytic activity of some hederagenin digly-
cosides. Chem Pharm Bull 52:965–971
Chwalek M, Lalun N, Bobichon H et al (2006) Structure-
activity relationships of some hederagenin diglycosides:
haemolysis, cytotoxicity and apoptosis induction. Bio-
chim Biophys Acta 1760:1418–1427
Cmoch P, Pakulski Z, Swaczynova J et al (2008) Synthesis of
lupane-type saponins bearing mannosyl and 3,6-branched
trimannosyl residues and their evaluation as anticancer
agents. Carbohydrate Res 343:995–1003
Dongre SH, Badami S, Ashok G et al (2007) In vitro cytotoxic
properties of O-methylsolanocapsine isolated from Sola-
num pseudocapsicum leaves. Indian J Pharmacol 39(4):
208–209
Einbond LS, Wen-Cai Y, He K et al (2008) Growth inhibitory
activity of extracts and compounds from Cimicifuga
species on human breast cancer cells. Phytomedicine
15:504–511
Ellington A, Berhow M, Singletary KW (2005) Induction of
macroautophagy in human colon cancer cells by soybean
B-group triterpenoid saponins. Carcinogenesis 26:
159–167
Fiore C, Eisenhut M, Ragazzi E et al (2005) A history of the
therapeutic use of liquorice in Europe. J Ethnopharmacol
99:317–324
Francis G, Kerem Z, Makkar HPS et al (2002) The biological
action of saponins in animal systems: a review. Br J Nutr
88:587–605
Fuchs H, Bachran D, Panijdeh H et al (2009) Saponins as tool
for improved targeted tumor therapies. Curr Drug Targets
10:140–151
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